syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
RECURRENT ACUTE PANCREATITIS	2.376392149	89.1530848761256
HEREDITARY ANGIOEDEMA TYPE 1	1.9032674999999997	71.40326946496378
AFRICAN IRON OVERLOAD	1.80182267	67.59744998224923
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516073
HEPATOCELLULAR CARCINOMA	1.4720718999999998	55.22647055524313
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	1.463977309	54.922792663206586
LYMPHEDEMA, HEREDITARY, III	1.3763795539999997	51.636462126489654
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.345413664	50.47474114512871
AUTOIMMUNE HEPATITIS	1.3350949799999998	50.087623845970384
SECKEL SYNDROME 10; SCKL10	1.25934579	47.24580585384751
MYOCLONIC-ASTASTIC EPILEPSY	1.220712254	45.796424313211524
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.20271637	45.12128802547887
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	1.1972155599999998	44.91491881111169
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.782803437094614
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15211626	43.222966696875915
LYMPHATIC MALFORMATION 1	1.1421568	42.849326099269156
HEPATOCELLULAR CARCINOMA	1.1145833	41.81487453079958
PULMONARY ARTERIOVENOUS MALFORMATION	1.083874719	40.662806792539094
CRANIOECTODERMAL DYSPLASIA 1	1.07100188	40.17986743068057
MOSAIC TRISOMY 1	1.0588235	39.722981496997186
WILSON DISEASE	1.04164923	39.07866900352265
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	1.0407583189999998	39.04524545260177
MONOSOMY 22Q13.3	1.0368301329999996	38.897875036479746
TEMPI SYNDROME	1.027027	38.530099226090584
COMPLEX REGIONAL PAIN SYNDROME	1.0263158	38.50341774004436
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	1.0204082	38.28178733092362
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	1.017013454	38.15442952998229
MEVALONIC ACIDURIA; MEVA	1.0163665039999998	38.13015845658857
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	1.01497094	38.0778022679038
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00934579	37.86676829541657
PREECLAMPSIA	1.0072002599999998	37.7862762696056
DISTAL 16P11.2 MICRODELETION SYNDROME	1.0010869729999998	37.556929276091736
LOWRY-MACLEAN SYNDROME	1.000541419	37.53646219026713
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0	37.516150233723735
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	1.0	37.516150233723735
ENTEROKINASE DEFICIENCY	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.0	37.516150233723735
CONGENITAL MACROGLOSSIA	1.0	37.516150233723735
CARDIAC-UROGENITAL SYNDROME; CUGS	1.0	37.516150233723735
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	1.0	37.516150233723735
PRIMARY SCLEROSING CHOLANGITIS	0.9982306599999999	37.449771408469196
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.9759633999999999	36.61438953701581
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
ISOLATED BILIARY ATRESIA	0.884160819	33.17031011637622
JUVENILE POLYPOSIS SYNDROME	0.875	32.826631454508274
MARTINEZ-FRIAS SYNDROME	0.833333	31.263446022719705
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.8047616	30.191557087931887
LAFORA DISEASE	0.7730060599999999	29.000211478538862
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7504837239999999	28.155260137548453
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.588780412607864
SOMATOSTATINOMA	0.7064654800000001	26.503865082619754
AGEL AMYLOIDOSIS	0.7014771	26.31672026911685
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.7	26.261305163606615
LYSINURIC PROTEIN INTOLERANCE	0.6844092900000001	25.6764017449962
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.681916754	25.58289138995723
ANGIOEDEMA, HEREDITARY, TYPE III	0.6635851000000001	24.895158304460598
MEIGE DISEASE	0.6604669	24.77817544480179
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.6582567500000001	24.69525912536273
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.622449579	23.35191191868209
DUPLICATION/INVERSION 15Q11	0.611652419	22.946844042024537
RING CHROMOSOME 13 SYNDROME	0.611111	22.926532085481142
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5942185099999999	22.29279089281947
GRAFT VERSUS HOST DISEASE	0.59266153	22.234378997228568
ALAGILLE SYNDROME 1; ALGS1	0.5910894200000001	22.17539948228463
ROLANDIC EPILEPSY	0.5906213	22.15783742203722
SICKLE CELL ANEMIA	0.5870825999999999	22.025079021205134
GALLBLADDER NEUROENDOCRINE TUMOR	0.5839289000000001	21.906764338213048
METACHROMATIC LEUKODYSTROPHY	0.582375619	21.848491214861856
MECKEL SYNDROME, TYPE 6; MKS6	0.5692983	21.35788055060353
MECKEL SYNDROME	0.5666667	21.259153049648457
LATHOSTEROLOSIS	0.566511189	21.253318875609462
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.56629196	21.245094247509876
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.565363104	21.210247146268376
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.563041419	21.123146463012997
DIAPHANOSPONDYLODYSOSTOSIS	0.559369054	20.985373465959928
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.5591847300000001	20.97845833908425
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5552631600000001	20.831336129812183
PETERS-PLUS SYNDROME; PTRPLS	0.553718573	20.773389171871127
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.54250426	20.35267132059512
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	20.097938161154147
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	20.06401605811282
HEREDITARY ANGIOEDEMA	0.5302521	19.893017445347503
ACQUIRED ANGIOEDEMA	0.5302521	19.893017445347503
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
SPLENOPORTAL VASCULAR ANOMALIES	0.52536235	19.709572849742152
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.525177614	19.70264226621257
ALAGILLE SYNDROME	0.52392578	19.65567827380089
PAROXYSMAL HEMICRANIA	0.5227273	19.610715918068777
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.520228924	19.516986468712446
MOSAIC TRISOMY 9	0.515470954	19.338485751384894
NUCHAL BLEB, FAMILIAL	0.5149254	19.318018665560288
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.51301586	19.246380076042982
CREST SYNDROME	0.50862069	19.081490218020228
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.502018519	18.833802178915494
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.501086973	18.798854159229872
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.501086973	18.798854159229872
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.500545554	18.778542202686477
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861868
PSEUDOXANTHOMA ELASTICUM; PXE	0.5	18.758075116861868
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.5	18.758075116861868
MATTHEW-WOOD SYNDROME	0.5	18.758075116861868
INHALATIONAL ANTHRAX	0.5	18.758075116861868
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.5	18.758075116861868
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	0.5	18.758075116861868
PRIMARY BILIARY CHOLANGITIS	0.4944281099999999	18.549039254536083
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.42766088999999996	16.044190198328
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.422928519	15.866649856930284
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064626
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.574128367585638
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.414724933	15.558882892099014
SARCOIDOSIS	0.41207636999999997	15.459519004687527
KLATSKIN TUMOR	0.41172833999999997	15.446462258921684
PMM2-CDG	0.41116820299999995	15.425448075078215
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062604
IMMUNE DEFICIENCY DISEASE	0.4047616	15.185096994442393
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.39458529	14.803321019657448
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.39458396	14.80327112317764
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.39154326	14.689195765161955
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.38960110400000003	14.616333548888626
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.570140138202744
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.37616221299999997	14.112158095157987
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.375541419	14.088868294189794
COG4-CDG	0.366796264	13.760783745392594
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.36356845899999995	13.639688928087427
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.360577999	13.527498381459488
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.36035523399999997	13.519141096252671
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.35683145299999997	13.386942398865928
CENTRALOPATHIC EPILEPSY	0.3547009	13.30701225243702
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.35022597	13.139130106271624
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.34964553	13.11735423202996
CHYLOMICRON RETENTION DISEASE	0.34660036	13.003111176822731
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.344263504	12.915441336052153
OVARIAN HYPERSTIMULATION SYNDROME	0.3418371	12.824411999060445
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.339499569	12.736716834888458
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.33859616	12.702824407121959
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.33831527	12.692286495682808
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.33503688	12.569293923918071
DUODENAL NEUROENDOCRINE TUMOR	0.33397086	12.529300957445916
CODAS SYNDROME	0.333878554	12.525837991682442
MITCHELL-RILEY SYNDROME; MTCHRS	0.3333333	12.505382160702904
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	12.505370905857834
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	12.505370905857834
PLACENTAL INSUFFICIENCY	0.333333	12.505370905857834
APOLIPOPROTEIN A-I; APOA1	0.333333	12.505370905857834
CHOLANGIOCARCINOMA	0.333333	12.505370905857834
16P12.1P12.3 TRIPLICATION SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.33018661	12.387330465923949
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.32847085	12.322961755998934
TRISOMY 8P	0.327464519	12.285208091018081
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32296934	12.1165662803266
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.321413119	12.058182859493726
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.32001584999999994	12.005762705772797
ARGININOSUCCINIC ACIDURIA	0.31638885299999997	11.869691741423534
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.31622816	11.863663158694028
ALSTROM SYNDROME; ALMS	0.307183194	11.524330855379104
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.3055556	11.463269794355597
WILSON DISEASE	0.30493573999999996	11.440015033471719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252717
LEPTOSPIROSIS	0.3010618299999999	11.294680843919792
SCLEROSING CHOLANGITIS, NEONATAL	0.29839536	11.194645154806079
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.2982093	11.187664899893592
HEMOCHROMATOSIS, NEONATAL	0.29807504999999995	11.182628356724713
CHOLANGIOCARCINOMA	0.29693016	11.139676491483627
PEUTZ-JEGHERS SYNDROME	0.291667	10.9422229902195
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.28888256	10.837761520862712
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.281158884	10.547998931690104
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.281158884	10.547998931690104
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.28062515	10.527975286761258
POTOCKI-LUPSKI SYNDROME	0.27936987300000005	10.480882126244323
EISENMENGER SYNDROME	0.27801968000000005	10.4302280828118
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.2763158	10.366305064751561
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.276190533	10.361605529160233
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.27432977	10.291796864902878
VIPOMA	0.27313218000000006	10.246867898544476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.272763619	10.233040908698182
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.27221555999999997	10.212479844917237
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.27221555999999997	10.212479844917237
BARE LYMPHOCYTE SYNDROME, TYPE II	0.2714286	10.182956135329308
GCGR-RELATED HYPERGLUCAGONEMIA	0.2712766	10.177253680493779
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.2712766	10.177253680493779
POEMS SYNDROME	0.2704082	10.144674655630814
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.26882296	10.085202553634307
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.26683558	10.01064370698281
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.26566238999999997	9.966630134690105
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.26490139	9.938080344362243
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.261508394	9.810788196683818
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.259667204	9.74171383603499
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.259237069	9.725576826754207
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.259237069	9.725576826754207
118900 CIRRHOSIS, FAMILIAL	0.25869565	9.705264870210813
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.25750815899999996	9.660714779453619
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.256172413	9.610602731843523
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.256166569	9.610383487461558
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.256166569	9.610383487461558
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.256101154	9.607929368494018
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.59025175850389
GLYCOGEN STORAGE DISEASE VI	0.25562515	9.590071530918166
CHILDHOOD APRAXIA OF SPEECH	0.2555556	9.58746228266941
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.2555556	9.58746228266941
LAMBERT SYNDROME	0.25526316	9.57649105969506
LAMBERT SYNDROME	0.25526316	9.57649105969506
PEHO SYNDROME; PEHO	0.25505497299999996	9.56868068492635
KETOADIPICACIDURIA	0.25505497299999996	9.56868068492635
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.25498227	9.56595314825591
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254042054	9.530679863547759
ACRAL SELF-HEALING COLLODION BABY	0.25396799999999997	9.52790164255835
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.25396799999999997	9.52790164255835
KASABACH-MERRITT SYNDROME	0.25327869	9.50204138504074
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.50204138504074
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.50204138504074
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.252564073	9.475231706309168
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.252450614	9.470975161419801
8P INVERTED DUPLICATION/DELETION SYNDROME	0.252446179	9.470808777293515
DISTAL TRISOMY 5Q	0.25190476	9.450496820750121
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.25170358	9.4429493216461
GLYCOGEN STORAGE DISEASE IXB	0.25170358	9.4429493216461
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2506428	9.403152939801172
PALLISTER-HALL SYNDROME	0.250545554	9.399504644255543
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.25	9.379037558430934
KETAMINE-INDUCED BILIARY DILATATION	0.25	9.379037558430934
MEDULLARY THYROID CARCINOMA	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
NEUROFIBROMA	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25	9.379037558430934
MENTAL RETARDATION, BUENOS AIRES TYPE	0.25	9.379037558430934
PEHO SYNDROME	0.24851375400000003	9.323279330210664
NAVAJO NEUROHEPATOPATHY	0.24767835400000004	9.291938338305412
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.24425798	9.163619073465888
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.118118511042523
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24223708000000005	9.087802685458557
GAUCHER DISEASE TYPE 1	0.23999372000000002	9.00364045467023
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.2399687	9.002701800591382
FIBROSCLEROSIS, MULTIFOCAL	0.237037	8.892715702951174
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.801844233919649
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.23069506000000004	8.654790529137912
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.230653289	8.6532234420265
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.22801686000000002	8.554314775581954
PPOMA	0.22774208000000004	8.544006087820732
GRFOMA	0.22774208000000004	8.544006087820732
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.226476114	8.496511917173944
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
HALOTHANE HEPATITIS	0.22567136	8.466320645208752
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.22472750000000002	8.430910651649153
BETA-THALASSEMIA INTERMEDIA	0.22309419	8.369635148310909
PYKNOACHONDROGENESIS	0.22272730000000002	8.355870847951657
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.22022892400000002	8.262141398595329
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.21837028000000003	8.192412231060318
TETRASOMY 9P	0.216588193	8.125555187438751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.21554631300000002	8.08646786083324
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21201585	7.954018480530636
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.21111110000000002	7.920075743606676
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.20696674	7.76459531122404
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.20666700000000002	7.753350220352983
GLUCAGONOMA	0.20646548000000003	7.745789965757885
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.205148293	7.696374180379976
CARCINOID SYNDROME	0.20392157000000002	7.650352256016813
CRYOGLOBULINEMIC VASCULITIS	0.20170358000000002	7.5671418099599155
ISOLATED POLYCYSTIC LIVER DISEASE	0.20170358000000002	7.5671418099599155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.201086973	7.544009089112749
TUBEROUS SCLEROSIS COMPLEX	0.2010849	7.543931318133315
BRANCHIOSKELETOGENITAL SYNDROME	0.200541419	7.52354200328814
LYMPHATIC MALFORMATION 7; LMPHM7	0.20018670000000002	7.5102343119933845
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744748
MODY	0.2	7.503230046744748
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744748
CARNEY COMPLEX	0.2	7.503230046744748
SCARF SYNDROME	0.2	7.503230046744748
SOLITARY BONE CYST	0.2	7.503230046744748
MYOTONIA FLUCTUANS	0.2	7.503230046744748
BLEPHAROCHALASIS, SUPERIOR	0.2	7.503230046744748
BLEPHAROCHALASIS AND DOUBLE LIP	0.2	7.503230046744748
HEPATIC ADENOMAS, FAMILIAL	0.2	7.503230046744748
EOSINOPHILIC FASCIITIS	0.2	7.503230046744748
AXIAL OSTEOMALACIA	0.2	7.503230046744748
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.2	7.503230046744748
CLEFT VELUM	0.2	7.503230046744748
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.19320676	7.248373834331007
PERIPARTUM CARDIOMYOPATHY	0.1929828	7.239971717324662
NON-HISTAMINIC ANGIOEDEMA	0.19190030000000002	7.199360484696656
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
NEPHRONOPHTHISIS 18; NPHP18	0.1888892	7.0863956047278895
LIVER FAILURE, INFANTILE, TRANSIENT	0.18781141	7.0459610731674855
SMITH-LEMLI-OPITZ SYNDROME	0.184910473	6.937129084856916
GRACILE SYNDROME	0.18312064	6.86998144113564
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.86452884386067
HELLP SYNDROME	0.18237036	6.841833823938283
MICROSPORIDIOSIS	0.181663919	6.815330877251021
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266897
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266897
CAROLI DISEASE, ISOLATED	0.17972128000000004	6.7424505406771305
H SYNDROME	0.17871520000000002	6.704706292249984
YELLOW NAIL SYNDROME	0.17777810000000002	6.669549907865963
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.177738004	6.66804566030619
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.17771637	6.667234035912034
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.177059543	6.6425924155024685
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.17699127	6.6400310753775615
TURNER SYNDROME	0.17672501000000002	6.63004202521633
MONOSOMY X	0.17672501000000002	6.63004202521633
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.17672501000000002	6.63004202521633
MOSAIC MONOSOMY X	0.17672501000000002	6.63004202521633
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.176255884	6.612442223721785
AICARDI SYNDROME; AIC	0.17511530000000003	6.569651903023603
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.17498253000000002	6.5646708837570715
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.17448916	6.546161540716258
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.174231054	6.536478397244033
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.172186154	6.459761621631091
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.1719299	6.450147958069098
UNILATERAL POLYMICROGYRIA	0.16990645999999998	6.374236279040173
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.169658733	6.364942515691223
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.169457553	6.357395016587203
LEIGH SYNDROME; LS	0.169231073	6.34889835888227
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.16911731400000002	6.344630559147832
DISTAL MONOSOMY 12Q	0.16911701399999998	6.34461930430276
13Q12.3 MICRODELETION SYNDROME	0.16857176000000001	6.324163473323222
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.167571403	6.286633929823865
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.167571403	6.286633929823865
LIGNEOUS CONJUNCTIVITIS	0.167212254	6.273160041983574
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1	0.166667	6.252704211004034
HYPERPLASTIC POLYPOSIS SYNDROME	0.166667	6.252704211004034
RIN2 SYNDROME	0.166667	6.252704211004034
NEOVASCULAR GLAUCOMA	0.166667	6.252704211004034
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.166667	6.252704211004034
ASCHER SYNDROME	0.166667	6.252704211004034
MÉNÉTRIER DISEASE	0.166667	6.252704211004034
AMOEBIC KERATITIS	0.166667	6.252704211004034
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.166667	6.252704211004034
FAMILIAL IDIOPATHIC STEROID-RESISTANT NEPHROTIC SYNDROME	0.166667	6.252704211004034
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.166667	6.252704211004034
NEPHROTIC SYNDROME, TYPE 15; NPHS15	0.166667	6.252704211004034
NEUROTROPHIC KERATOPATHY	0.166667	6.252704211004034
SCALP-EAR-NIPPLE SYNDROME; SENS	0.1655843	6.21208547514598
SCALP-EAR-NIPPLE SYNDROME	0.1655843	6.21208547514598
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.1648841	6.185816666752328
RARE HEREDITARY HEMOCHROMATOSIS	0.16475635	6.18102397855997
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.161783464	6.069492740756235
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.16025640000000002	6.012203178315725
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
FAMILIAL PANCREATIC CARCINOMA	0.15932823000000002	5.97738181315329
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.15882677	5.958568964457086
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.15854980000000002	5.948178116326853
CONGENITAL ENTEROVIRUS INFECTION	0.15816579	5.933771539475599
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.15663521900000002	5.876350407896219
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.155878654	5.8479670016946415
WOLF-HIRSCHHORN SYNDROME	0.154591073	5.799661919460553
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.727283548976788
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.687129488155532
ENHANCED S-CONE SYNDROME	0.15147769	5.682859775097432
BECKWITH-WIEDEMANN SYNDROME	0.15005528	5.629496427843481
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.14970512000000002	5.616359772677641
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14786326000000002	5.547260276208155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.147740053	5.542638023886308
JOHANSON-BLIZZARD SYNDROME; JBS	0.1472222	5.523210172939322
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.146899054	5.511086979055896
XANTHINURIA, TYPE I	0.14664487999999998	5.501551349086388
ACERULOPLASMINEMIA	0.14623886	5.486319041768493
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.14549495399999998	5.458410552512723
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.1454082	5.455155876415348
NEUROFIBROMATOSIS TYPE 1	0.14487551899999998	5.435171735992697
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14476176	5.430903936258259
COMBINED SAPOSIN DEFICIENCY	0.14456058	5.423356437154238
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14438761	5.4168672686483115
SCHINZEL-GIEDION SYNDROME	0.14285720000000002	5.359452177169119
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.14285699999999998	5.3594446739390715
RETINITIS PIGMENTOSA 27; RP27	0.14285699999999998	5.3594446739390715
POSTERIOR URETHRAL VALVE	0.14285699999999998	5.3594446739390715
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14285699999999998	5.3594446739390715
HAND-FOOT-GENITAL SYNDROME; HFG	0.14285699999999998	5.3594446739390715
WOLFRAM-LIKE SYNDROME	0.14285699999999998	5.3594446739390715
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14285699999999998	5.3594446739390715
STEINERT MYOTONIC DYSTROPHY	0.14285699999999998	5.3594446739390715
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.14285699999999998	5.3594446739390715
IDIOPATHIC ANTERIOR UVEITIS	0.14285699999999998	5.3594446739390715
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14285699999999998	5.3594446739390715
IRVAN SYNDROME	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
DISTAL TRISOMY 14Q	0.14285699999999998	5.3594446739390715
RETINITIS PIGMENTOSA 11	0.14285699999999998	5.3594446739390715
LYMPHEDEMA, HEREDITARY, II	0.14215680000000003	5.33317586554542
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.14116840000000003	5.296094902654407
AL AMYLOIDOSIS	0.14026438000000002	5.262179552520116
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.138693714	5.203254210897113
TRICHOHEPATOENTERIC SYNDROME 1	0.13866399000000001	5.202139080847566
HENNEKAM SYNDROME	0.137688919	5.165558170723019
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.136382004	5.116527751240311
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.1359649	5.100879614913224
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.13438346	5.0415500742876045
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.134261954	5.036991636937305
CASTLEMAN DISEASE	0.13354185	5.0099761070893996
WILLIAMS SYNDROME	0.1327317	4.979582397977549
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.1302521	4.886557351858007
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.130193104	4.884344049058819
INTESTINAL LYMPHANGIECTASIA	0.13005730000000001	4.879249205792479
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.12957786000000002	4.861262462724422
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.12835239999999998	4.815287921259002
FUCOSIDOSIS	0.127790553	4.794209584798636
TRIPLOIDY	0.12670358	4.7534305424306345
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.126086973	4.730297821583468
TRANSALDOLASE DEFICIENCY	0.12572612000000002	4.716760006223179
VACTERL/VATER ASSOCIATION	0.125	4.689518779215467
GENITOPALATOCARDIAC SYNDROME	0.125	4.689518779215467
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.125	4.689518779215467
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.125	4.689518779215467
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.125	4.689518779215467
PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE	0.125	4.689518779215467
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.124672414	4.677229013625003
SOLAR URTICARIA	0.12406020000000001	4.6542611012258135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.123884573	4.647672252308715
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12293675000000001	4.612113582245738
LYMPHANGIOLEIOMYOMATOSIS	0.12276351899999999	4.605614622024598
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.12219530399999999	4.584297382719543
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.121460199	4.5567190731019815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12091581399999998	4.536295843656996
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.120614029	4.5249740322587115
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12005800999999999	4.504114339921907
WILD TYPE ATTR AMYLOIDOSIS	0.11985618	4.496542455320234
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427327
SYSTEMIC CAPILLARY LEAK SYNDROME	0.11815260000000001	4.432630692105068
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.11747741000000002	4.40730016262876
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.11626946900000001	4.361982866599285
LYSOSOMAL ACID LIPASE DEFICIENCY	0.11536828400000002	4.328173874750907
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.1150926	4.317831272389873
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.11489887999999998	4.310563643766595
NIEMANN-PICK DISEASE TYPE B	0.11474503	4.304791784053137
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.11428187000000001	4.287415803910886
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.11323059000000002	4.247975825493178
IMMUNODEFICIENCY 23; IMD23	0.11313365399999999	4.24433915995412
JOUBERT SYNDROME 2	0.11313365399999999	4.24433915995412
PGM3-CDG	0.11312951899999998	4.244184030672903
REFSUM DISEASE	0.11258809999999998	4.223872074129511
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.11221571000000001	4.209901434943975
COFFIN-SIRIS SYNDROME 1; CSS1	0.11219797299999999	4.209236010987279
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.11219797299999999	4.209236010987279
DOWN SYNDROME	0.11190470000000001	4.198233537059784
MICROVILLUS INCLUSION DISEASE	0.11165655399999999	4.188924054443887
NON-DISTAL MONOSOMY 20Q	0.11165241899999999	4.1887689251626705
FRYNS SYNDROME; FRNS	0.11165241899999999	4.1887689251626705
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.11165241899999999	4.1887689251626705
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.11165241899999999	4.1887689251626705
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11111120000000001	4.168464471849325
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.11111099999999999	4.168456968619277
SEVERE CONGENITAL NEMALINE MYOPATHY	0.11111099999999999	4.168456968619277
WELL-DIFFERENTIATED LIPOSARCOMA	0.11111099999999999	4.168456968619277
RADIO-RENAL SYNDROME	0.11111099999999999	4.168456968619277
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.11111099999999999	4.168456968619277
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.11111099999999999	4.168456968619277
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11111099999999999	4.168456968619277
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.11111099999999999	4.168456968619277
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.11090585400000001	4.160760680463431
MILROY DISEASE	0.10964910000000001	4.113612108592598
CITRULLINEMIA TYPE II	0.109429113	4.1053590432511315
BETA-THALASSEMIA MAJOR	0.10752725999999999	4.034008840380673
HEMOCHROMATOSIS TYPE 4	0.10743544	4.030564107466212
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.106758864	4.00518158060568
BILATERAL POLYMICROGYRIA	0.106565524	3.9979282081194922
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.106166569	3.9829609524029976
HARDIKAR SYNDROME	0.10557271000000001	3.9606816489413483
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.105527824	3.9589976990219578
BUDD-CHIARI SYNDROME	0.10533976	3.9519422617444024
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.10450580000000001	3.9206552930954865
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10438218	3.916017546603593
NOCARDIOSIS	0.10428291900000002	3.9122936560152444
MELIOIDOSIS	0.10374150000000001	3.891981699471852
AICARDI SYNDROME	0.1036867	3.8899258144390427
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.10266750000000001	3.8516893541208317
WALDENSTRÖM MACROGLOBULINEMIA	0.10253628000000001	3.846766484887163
ADAMS-OLIVER SYNDROME	0.102438259	3.843089114325103
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.10230656300000002	3.838148387403923
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.102249134	3.8359938724121503
ACROCEPHALOSYNDACTYLY	0.10195418	3.824928333836112
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.8154900207603113
CONGENITAL ISOLATED ACTH DEFICIENCY	0.10096379999999999	3.7877730889676364
INSULIN-RESISTANCE SYNDROME TYPE B	0.10050099	3.7704102394779673
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.10032689400000001	3.763878827786877
BARDET-BIEDL SYNDROME 1; BBS1	0.10025271399999999	3.761095879762539
SYNDROMIC DIARRHEA	0.099040084	3.715602670504618
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.7123395157572894
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.09880425400000001	3.706755236795
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0984556	3.6936750809514107
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09839385400000002	3.69135860873908
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.09839385400000002	3.69135860873908
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.09839385400000002	3.69135860873908
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810905
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810905
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.09744489	3.655757132748684
KAWASAKI DISEASE	0.09679205	3.6312650892300997
KAPOSI SARCOMA	0.0957671	3.592812911048044
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.09575837000000001	3.5924853950565043
SIALURIA	0.09559252300000001	3.586263454088692
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.095558899	3.585002011053233
KAGAMI-OGATA SYNDROME	0.095242873	3.5731459321594703
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.09480348000000001	3.556661598359824
ENTERIC ANENDOCRINOSIS	0.0946844	3.552194175189992
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.09444440000000001	3.5431902991338986
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.09444440000000001	3.5431902991338986
BLAU SYNDROME	0.09415590000000001	3.5323668897914695
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.09354038	3.509274948999607
NEPHRONOPHTHISIS 19; NPHP19	0.09322408000000001	3.4974085906806813
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955697
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.093025213	3.4899478664321504
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.09282763999999999	3.4825356880820224
MECKEL SYNDROME, TYPE 5	0.09263160000000001	3.4751810219902044
COACH SYNDROME	0.092521673	3.4710569841434613
NEONATAL HEMOCHROMATOSIS	0.09166669999999999	3.438981688629683
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.090911713	3.4106574829131757
DDOST-CDG	0.09073187900000002	3.4039108035520447
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.090170404	3.3828464230995636
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.089585314	3.360896098759315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08896295400000001	3.337547547499854
CIRRHOSIS, FAMILIAL	0.08859646000000002	3.323798103536096
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.088481873	3.319499240429264
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0881577	3.307337517459547
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.08661199000000001	3.2493484288817784
THANATOPHORIC DYSPLASIA TYPE 2	0.086391919	3.2410922121836916
THANATOPHORIC DYSPLASIA TYPE 1	0.086391919	3.2410922121836916
THANATOPHORIC DYSPLASIA	0.086391919	3.2410922121836916
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.085794449	3.218677437903549
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.08535181900000001	3.202071664325597
CONGENITAL ANALBUMINEMIA	0.0851393	3.1940987695940755
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.08503688000000001	3.190256365487137
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.08503688000000001	3.190256365487137
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.08503688000000001	3.190256365487137
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.08503688000000001	3.190256365487137
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.08503688000000001	3.190256365487137
CHRONIC GRANULOMATOUS DISEASE	0.08503688000000001	3.190256365487137
VON HIPPEL-LINDAU DISEASE	0.08481040000000001	3.1817597077822035
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.08480203400000001	3.1814458476693486
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.084692319	3.177329763246455
BURKITT LYMPHOMA	0.08465600000000001	3.1759672141861173
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.08465600000000001	3.1759672141861173
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08456676900000001	3.1726196105846114
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.08442027300000002	3.167123644639972
ILEAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.150263399014983
JEJUNAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.150263399014983
%300712 CRANIOFACIOSKELETAL SYNDROME	0.08387885400000002	3.1468116880965797
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.08347680000000002	3.1317281698305104
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	3.126344602271971
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.08333330000000001	3.126344602271971
MYCETOMA	0.08333330000000001	3.126344602271971
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.08333330000000001	3.126344602271971
184705 STEINFELD SYNDROME	0.08333330000000001	3.126344602271971
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.08333330000000001	3.126344602271971
PENTALOGY OF CANTRELL	0.08333330000000001	3.126344602271971
PAPILLON-LEFÈVRE SYNDROME	0.08333330000000001	3.126344602271971
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	3.126344602271971
BULLOUS IMPETIGO	0.08333330000000001	3.126344602271971
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	3.126344602271971
FAMILIAL MELANOMA	0.08333330000000001	3.126344602271971
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.08333330000000001	3.126344602271971
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.08333330000000001	3.126344602271971
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.08333330000000001	3.126344602271971
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.08333330000000001	3.126344602271971
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.08333330000000001	3.126344602271971
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.08312401900000001	3.118493184834907
DILATED CARDIOMYOPATHY WITH ATAXIA	0.082863189	3.1087078473694443
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.08254825	3.0968925485309855
ALPORT SYNDROME	0.08222609	3.084806345571689
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.08167787900000001	3.064239579335909
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.0815921	3.0610214814850103
CHROMOSOME 1P36 DELETION SYNDROME	0.081507633	3.057852604823218
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08096515400000001	3.037500881160579
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08051991	3.020797040365914
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08020179000000001	3.008862402653562
CRIGLER-NAJJAR SYNDROME TYPE 1	0.08007777900000002	3.004209987346928
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.08004929000000001	3.0031411897429194
ETHYLMALONIC ENCEPHALOPATHY	0.078941619	2.9615856380973806
GRISCELLI SYNDROME TYPE 2	0.07893675900000001	2.9614033096072445
DISORDER OF BILE ACID SYNTHESIS	0.07877537	2.955348615637174
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.07839534000000001	2.941091353063852
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.07824334000000001	2.935388898228326
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.07777780000000001	2.9179236296485183
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.07777780000000001	2.9179236296485183
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.07777780000000001	2.9179236296485183
MPI-CDG	0.0777778	2.917923629648518
RETINITIS PIGMENTOSA 59; RP59	0.077595169	2.911072017615183
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.07749784300000001	2.9074207207775355
NEUTRAL LIPID STORAGE MYOPATHY	0.07747093999999999	2.906411423787797
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.906325661868364
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07746451900000001	2.906170532587147
FETAL PARVOVIRUS SYNDROME	0.07702759	2.8897786385816766
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.8858585760437547
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.8858585760437547
ZOLLINGER-ELLISON SYNDROME	0.07669176000000001	2.877179589848685
LYSINURIC PROTEIN INTOLERANCE; LPI	0.07641087	2.8666416784095343
GAUCHER DISEASE, PERINATAL LETHAL	0.07639538900000001	2.8660608908877663
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.076140499	2.856498399354692
NEURAMINIDASE DEFICIENCY	0.075993899	2.8509985317304283
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0759638	2.849869333124543
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0759638	2.849869333124543
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.07535017000000001	2.8268482978566234
CRYPTOCOCCOSIS	0.075099769	2.8174542163219485
AMYLOIDOSIS	0.0748664	2.808699109858055
YUNIS-VARON SYNDROME	0.07429445400000001	2.787241897796478
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07427589999999999	2.786545823145041
SIMPSON-GOLABI-BEHMEL SYNDROME	0.07421915300000001	2.784416894167728
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.07421915300000001	2.784416894167728
TRISOMY 1Q	0.0737489	2.7667748119718687
HISTIOCYTOID CARDIOMYOPATHY	0.073673599	2.763949808343119
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.07321722	2.746828225215602
BECKWITH-WIEDEMANN SYNDROME	0.07313218	2.743637851799727
MASTOCYTOSIS	0.07313218	2.743637851799727
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.07313218	2.743637851799727
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.07313218	2.743637851799727
TURCOT SYNDROME WITH POLYPOSIS	0.0729057	2.7351411940947927
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7346876238384668
SMITH-MAGENIS SYNDROME; SMS	0.07240353299999999	2.716301821480374
DK1-CDG	0.07229184999999999	2.712111905273821
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.072194524	2.7084606084361735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
NETHERTON SYNDROME; NETH	0.07197415400000001	2.700193174409169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
IMMUNOGLOBULIN A VASCULITIS	0.07197001900000001	2.700038045127952
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.07197001900000001	2.700038045127952
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.07197001900000001	2.700038045127952
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.07197001900000001	2.700038045127952
GRISCELLI SYNDROME, TYPE 2; GS2	0.07197001900000001	2.700038045127952
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.07142860000000001	2.6797260885845593
CRYPTOSPORIDIOSIS	0.07142860000000001	2.6797260885845593
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6797260885845593
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.07142860000000001	2.6797260885845593
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.07142860000000001	2.6797260885845593
RETINITIS PIGMENTOSA 77; RP77	0.07142860000000001	2.6797260885845593
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.07142860000000001	2.6797260885845593
IDIOPATHIC PANUVEITIS	0.07142860000000001	2.6797260885845593
CARBOXYPEPTIDASE N DEFICIENCY	0.07142860000000001	2.6797260885845593
PULMONARY EDEMA OF MOUNTAINEERS	0.07142860000000001	2.6797260885845593
ALAGILLE SYNDROME 2	0.07142860000000001	2.6797260885845593
INTERMEDIATE UVEITIS	0.07142860000000001	2.6797260885845593
RETINITIS PUNCTATA ALBESCENS	0.07142860000000001	2.6797260885845593
RETINITIS PIGMENTOSA 83; RP83	0.07142860000000001	2.6797260885845593
PSORIASIS 14, PUSTULAR	0.07142860000000001	2.6797260885845593
GARDNER SYNDROME	0.07142860000000001	2.6797260885845593
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6797260885845593
RETINITIS PIGMENTOSA 76; RP76	0.07142860000000001	2.6797260885845593
BIRDSHOT CHORIORETINOPATHY	0.07142860000000001	2.6797260885845593
ACQUIRED ANGIOEDEMA	0.07142860000000001	2.6797260885845593
MICROPHTHALMIA, ISOLATED 5	0.07142860000000001	2.6797260885845593
RETINITIS PIGMENTOSA 13; RP13	0.07142860000000001	2.6797260885845593
RETINITIS PIGMENTOSA 78; RP78	0.07142860000000001	2.6797260885845593
JOUBERT SYNDROME 6	0.07132095399999999	2.6756876250764994
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.070875373	2.658971141339207
HEMOCHROMATOSIS TYPE 2	0.07058827	2.648200142058654
ALPHA-THALASSEMIA	0.07003656	2.6275021068132065
RHABDOID TUMOR	0.06994539	2.6240817593963977
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.0699346	2.6236769601353758
OROFACIODIGITAL SYNDROME I; OFD1	0.06983971900000001	2.6201173902850505
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.06895295300000001	2.5868493438068922
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
SENIOR-LOKEN SYNDROME	0.068689354	2.5769601241214324
LAURENCE-MOON SYNDROME	0.06814379999999999	2.556493038296823
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06792670399999999	2.5483484321456826
GLYCOGEN STORAGE DISEASE IV	0.06754573999999999	2.5340561294880426
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
EPENDYMOMA	0.067208119	2.5213898893299826
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.067208119	2.5213898893299826
SUBEPENDYMOMA	0.067208119	2.5213898893299826
GLYCOGEN STORAGE DISEASE IXC	0.0669524	2.511796296908365
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.066829299	2.5071780212984436
GAUCHER DISEASE	0.06679013	2.505708551209939
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.066703819	2.502470494767116
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.50107793278659
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.50107793278659
MUIR-TORRE SYNDROME	0.0666667	2.50107793278659
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.50107793278659
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.50107793278659
NEPHROBLASTOMA	0.0666667	2.50107793278659
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.0666667	2.50107793278659
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
ADENOCARCINOMA OF THE ANAL CANAL	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.50107793278659
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
TRANSALDOLASE DEFICIENCY	0.06652049399999999	2.495592846525518
REYNOLDS SYNDROME	0.06644391000000001	2.492719709676019
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.4870168796789907
SLC35A2-CDG	0.06613702399999999	2.481206528395392
HEMOCHROMATOSIS, TYPE 1	0.065979	2.4752780762708584
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.06589500899999999	2.4721270572965772
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.06548385000000001	2.4567019544826305
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.06533011899999999	2.450934559191049
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.063041419	2.365071346151126
COCAINE EMBRYOFETOPATHY	0.0627273	2.3532868105558586
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.348430344908104
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.06210219	2.329835089883256
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.06200055	2.3260219483735
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.061614053	2.311522068856617
1P36 DELETION SYNDROME	0.061548263	2.3090538813327397
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.06153544	2.308572811738293
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.061512412999999995	2.307708927346861
HEREDITARY ELLIPTOCYTOSIS	0.061202	2.29606342660436
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.06088831000000001	2.2842949854375436
NOONAN SYNDROME	0.060433680000000004	2.267239018056786
19P13.13 MICRODELETION SYNDROME	0.059910473	2.2476103056414494
BLAU SYNDROME	0.0597643	2.2421264574133355
DUBIN-JOHNSON SYNDROME	0.05959834000000001	2.235900277120547
GRISCELLI SYNDROME	0.059533503	2.2334678424878427
FOUNTAIN SYNDROME	0.059364919	2.227143219816841
FOUNTAIN SYNDROME	0.059364919	2.227143219816841
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.059364919	2.227143219816841
CORNELIA DE LANGE SYNDROME	0.059364919	2.227143219816841
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	0.0588235	2.206831263273448
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0588235	2.206831263273448
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.0588235	2.206831263273448
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0588235	2.206831263273448
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0588235	2.206831263273448
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.0588235	2.206831263273448
HYDROPS FETALIS, NONIMMUNE	0.0588235	2.206831263273448
MELKERSSON-ROSENTHAL SYNDROME	0.0588235	2.206831263273448
CITRULLINEMIA, CLASSIC	0.058417803000000004	2.1916110736720773
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.058147619000000005	2.181474810137329
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.058119673000000004	2.180426383802897
PORPHYRIA CUTANEA TARDA	0.05791213	2.1726401694349393
DUBIN-JOHNSON SYNDROME	0.05789476	2.17198851390538
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0578571	2.170575655687578
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.167604751750569
CYSTIC FIBROSIS	0.05725918000000001	2.1481439991398297
8Q24.3 MICRODELETION SYNDROME	0.056642573	2.125011278292664
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.05662898	2.124501321262537
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.05655317	2.1216572219133183
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.05651325000000001	2.120159577195988
219400 CYANOSIS AND HEPATIC DISEASE	0.056122500000000006	2.105500141492161
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492713
FLOATING-HARBOR SYNDROME	0.056101154	2.1046993217492713
WHITE-SUTTON SYNDROME; WHSUS	0.056101154	2.1046993217492713
17P11.2 MICRODUPLICATION SYNDROME	0.056101154	2.1046993217492713
LATHOSTEROLOSIS	0.056069243000000005	2.1035021438791635
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.05591029	2.0975388392510617
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.05591029	2.0975388392510617
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.05591029	2.0975388392510617
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.05591029	2.0975388392510617
CYSTIC FIBROSIS	0.055555600000000004	2.0842322359246626
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	2.0842322359246626
GITELMAN SYNDROME	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.055555600000000004	2.0842322359246626
BILIARY CIRRHOSIS, PRIMARY	0.055555600000000004	2.0842322359246626
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	2.0842322359246626
FLOATING-HARBOR SYNDROME	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	2.0842322359246626
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.055435519	2.079727259088447
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.054777714000000005	2.055048947883952
SILVER-RUSSELL SYNDROME; SRS	0.054522853999999996	2.0454875818353853
POLYCYSTIC LIVER DISEASE 2	0.054335180000000004	2.0384467758564213
AMERICAN TRYPANOSOMIASIS	0.054335180000000004	2.0384467758564213
COG2-CDG	0.05426045399999999	2.0356433440140558
KIKUCHI-FUJIMOTO DISEASE	0.05351644	2.007730803014062
GRANULOMATOSIS WITH POLYANGIITIS	0.053173019	1.9948469691846469
LEUKOCYTE ADHESION DEFICIENCY	0.053173019	1.9948469691846469
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.053173019	1.9948469691846469
CONGENITAL MEMBRANOUS NEPHROPATHY DUE TO FETOMATERNAL ANTI-NEUTRAL ENDOPEPTIDASE ALLOIMMUNIZATION	0.0526316	1.9745350126412542
LACRIMAL DUCT DEFECT	0.0526316	1.9745350126412542
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.0526316	1.9745350126412542
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0526316	1.9745350126412542
POLYCYSTIC KIDNEYS	0.0526316	1.9745350126412542
POLYCYSTIC KIDNEY DISEASE 3	0.0526316	1.9745350126412542
NAIL-PATELLA SYNDROME	0.0526316	1.9745350126412542
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0526316	1.9745350126412542
PEUTZ-JEGHERS SYNDROME	0.0526316	1.9745350126412542
POLYCYSTIC KIDNEY DISEASE 2	0.0526316	1.9745350126412542
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0526316	1.9745350126412542
ROBERTS SYNDROME; RBS	0.0526316	1.9745350126412542
NEPHRONOPHTHISIS 13	0.0526316	1.9745350126412542
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9745350126412542
ACUTE MONOBLASTIC LEUKEMIA	0.0526316	1.9745350126412542
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0526316	1.9745350126412542
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.0526316	1.9745350126412542
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0526316	1.9745350126412542
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0526316	1.9745350126412542
MELKERSSON-ROSENTHAL SYNDROME	0.0526316	1.9745350126412542
GOODPASTURE SYNDROME	0.0526316	1.9745350126412542
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.0526316	1.9745350126412542
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0526316	1.9745350126412542
DERMATOMYOSITIS	0.0526316	1.9745350126412542
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0526316	1.9745350126412542
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.0526316	1.9745350126412542
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0526316	1.9745350126412542
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0526316	1.9745350126412542
MECKEL SYNDROME, TYPE 4; MKS4	0.0526316	1.9745350126412542
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0526316	1.9745350126412542
VISCERAL STEATOSIS, CONGENITAL	0.052187369000000004	1.9578691757067772
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0514889	1.9316653077691779
CEPHALIN LIPIDOSIS	0.05140688	1.9285882331270081
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.050642523999999994	1.8999125385989597
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.050436504	1.8921834613278083
RETINAL VENOUS BEADING	0.050287389999999994	1.8865892781018565
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05026319	1.8856813872662006
12Q14 MICRODELETION SYNDROME	0.050069314	1.878407906123487
IRIDA SYNDROME	0.05	1.875807511686187
MEDNIK SYNDROME	0.05	1.875807511686187
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.049322580000000005	1.850393321194858
IMMUNODEFICIENCY 47	0.049208009	1.8460950583464297
MCLEOD SYNDROME; MCLDS	0.0490852	1.8414877374523766
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
ADULT-ONSET STILL DISEASE	0.048760649999999996	1.8293118708940213
HOLOPROSENCEPHALY	0.048705973	1.827260600347692
LISSENCEPHALY 2; LIS2	0.048693653999999996	1.8267984388929626
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.04865153999999999	1.8252184837420193
LYSOSOMAL ACID LIPASE DEFICIENCY	0.04845992	1.8180296390342334
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.048272854	1.8110116428746117
CONGENITAL HYPOTHYROIDISM	0.048272854	1.8110116428746117
DEXTROCARDIA	0.048164554	1.8069486438042994
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.048130104	1.8056562124287479
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.047762500000000006	1.7918651255382303
MEACHAM SYNDROME	0.047619	1.7864815579796907
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.047619	1.7864815579796907
TUFTSIN DEFICIENCY	0.047619	1.7864815579796907
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	1.7864815579796907
PAGOD SYNDROME	0.047619	1.7864815579796907
FEINGOLD SYNDROME	0.047619	1.7864815579796907
CEROID STORAGE DISEASE	0.047619	1.7864815579796907
MAPLE SYRUP URINE DISEASE; MSUD	0.047473019000000005	1.7810049128524217
SIALIDOSIS TYPE 2	0.047413613	1.7787762284316369
THYROCEREBRORETINAL SYNDROME	0.04696390899999999	1.76190506560693
LASSA FEVER	0.046955608999999995	1.7615936815599902
300270 ADRENOMYODYSTROPHY	0.046928344	1.7605708037238679
BETA-THALASSEMIA	0.04666707	1.7507688090877018
RHEUMATOID ARTHRITIS	0.0466532	1.7502484600839603
MUCOPOLYSACCHARIDOSIS TYPE 7	0.04644469999999999	1.7424263427602287
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.046203244000000004	1.7333678431893949
GLIOBLASTOMA	0.045995919	1.7255898073421883
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.045995919	1.7255898073421883
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.045995919	1.7255898073421883
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.718719887427539
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.7173038028208167
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04565769	1.712900757364786
MYH9-RELATED DISEASE	0.04558826999999999	1.7102963862155607
TYROSINEMIA, TYPE I; TYRSN1	0.0455708	1.709640979070978
THYROCEREBRORENAL SYNDROME	0.045486808999999996	1.706489960096697
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.045486808999999996	1.706489960096697
SOMATOMAMMOTROPINOMA	0.0454546	1.705281602413819
ACROMEGALY	0.0454546	1.705281602413819
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.045454579999999994	1.7052808520908143
ALPORT SYNDROME, X-LINKED; ATS	0.044945389999999995	1.6861780035533043
FECHTNER SYNDROME	0.044945389999999995	1.6861780035533043
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.044839079999999996	1.6821896616219572
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.04466131	1.6755204155949084
ERDHEIM-CHESTER DISEASE	0.044612599999999995	1.6736930039170232
CONGENITAL TRACHEAL STENOSIS	0.0442684	1.6607799450065759
ALSTRÖM SYNDROME	0.04408779299999999	1.6540042656613134
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.04386722	1.6457292158558106
ALKAPTONURIA	0.04378788	1.642752684496267
HYPERBILIVERDINEMIA; HBLVD	0.043498800000000004	1.6319075157867025
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.04337028	1.6270859401586637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6225267524853604
KOOLEN-DE VRIES SYNDROME; KDVS	0.042991733	1.6128843140361382
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04279685	1.6055730541301396
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.042069579999999995	1.5782886835496592
AICARDI-GOUTIÈRES SYNDROME	0.04205674300000001	1.5778070887291094
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.576501939378628
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04201927	1.5764012460314007
PELIZAEUS-MERZBACHER DISEASE	0.042018519000000004	1.5763730714025754
MENTAL RETARDATION, X-LINKED 98; MRX98	0.041739532999999995	1.5659065907134693
COMPLEMENT COMPONENT C1R DEFICIENCY	0.041666699999999994	1.5631741769434964
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.041666699999999994	1.5631741769434964
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.041666699999999994	1.5631741769434964
DYSCHONDROSTEOSIS AND NEPHRITIS	0.041666699999999994	1.5631741769434964
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.041666699999999994	1.5631741769434964
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.041666699999999994	1.5631741769434964
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.041666699999999994	1.5631741769434964
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041661114000000006	1.5629646117282914
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0414771	1.5560611148591827
NEONATAL ADRENOLEUKODYSTROPHY	0.041366299	1.551904287897136
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.041205109999999996	1.5458570971571122
FANCONI ANEMIA	0.040861244	1.5329565686408424
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	1.5315923313537436
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.04059248000000001	1.5228735780394262
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.04059248	1.5228735780394262
TRISOMY 12P	0.040545554	1.5211130951735583
KAPUR-TORIELLO SYNDROME	0.040541419	1.520957965892342
CHRISTIANSON SYNDROME	0.0405335	1.520660875498641
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.04031569	1.5124894828162336
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04031569	1.5124894828162336
DK PHOCOMELIA SYNDROME	0.04031569	1.5124894828162336
PRIMARY MYELOFIBROSIS	0.04028627	1.5113857576763576
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.5006460093489495
BLACKFAN-DIAMOND ANEMIA	0.04	1.5006460093489495
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.5006460093489495
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.5006460093489495
3Q13 MICRODELETION SYNDROME	0.04	1.5006460093489495
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.5006460093489495
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.5006460093489495
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	1.5006460093489495
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.5006460093489495
NON-DISTAL TRISOMY 10Q	0.04	1.5006460093489495
PORPHYRIA CUTANEA TARDA	0.03994565	1.4986070065837467
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03994565	1.4986070065837467
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.0399254	1.4978473045415135
ADAMS-OLIVER SYNDROME 6; AOS6	0.0399225	1.4977385077058358
AMISH INFANTILE EPILEPSY SYNDROME	0.03989015	1.4965248602457748
MUCOLIPIDOSIS IV; ML4	0.03975635400000001	1.4915053494091037
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.039708304	1.4897026983903732
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.039502180000000005	1.4819697194395973
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.039502180000000005	1.4819697194395973
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.039502180000000005	1.4819697194395973
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.039502180000000005	1.4819697194395973
16P13.11 MICRODELETION SYNDROME	0.039487314	1.4814120043502226
HYPERLYSINEMIA, TYPE I	0.039483179	1.4812568750690063
SENIOR-LOKEN SYNDROME 9	0.039434454	1.479428900648868
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.039162749999999996	1.4692356125657642
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.039093649999999994	1.4666432465846138
LEPRECHAUNISM	0.038888900000000004	1.4589618148242591
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.03859294	1.4478585350010862
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
MYOCLONUS AND ATAXIA	0.0385141	1.4449007617166596
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
LISSENCEPHALY 5; LIS5	0.037629319	1.411707184796715
TRICHOTHIODYSTROPHY	0.037582554	1.4099527420310347
SLC39A8-CDG	0.037578419	1.4097976127498186
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.037221679	1.3964141013154399
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0370879	1.3913952282533226
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.037037179999999996	1.389492409113468
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.389485656206426
RHYNS SYNDROME	0.037037	1.389485656206426
SITOSTEROLEMIA	0.037037	1.389485656206426
NATHALIE SYNDROME	0.037037	1.389485656206426
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.389485656206426
PEYRONIE DISEASE	0.037037	1.389485656206426
SCIMITAR SYNDROME	0.037037	1.389485656206426
ATRANSFERRINEMIA	0.037037	1.389485656206426
BENIGN SCHWANNOMA	0.037037	1.389485656206426
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.389485656206426
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.389485656206426
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.389485656206426
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.389485656206426
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.389485656206426
URINARY BLADDER, ATONY OF	0.037037	1.389485656206426
POLAND SYNDROME	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.389485656206426
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.389485656206426
TESTICULAR TORSION	0.037037	1.389485656206426
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.389485656206426
CANAVAN DISEASE	0.037037	1.389485656206426
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.389485656206426
JEUNE SYNDROME	0.037037	1.389485656206426
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.389485656206426
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.389485656206426
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.389485656206426
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.389485656206426
ADENOMYOSIS	0.037037	1.389485656206426
GALACTORRHEA	0.037037	1.389485656206426
GENITOURINARY TRACT ANOMALIES	0.037037	1.389485656206426
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.389485656206426
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.389485656206426
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.389485656206426
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.389485656206426
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.389485656206426
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	1.389485656206426
SYSTEMIC MASTOCYTOSIS	0.03693372	1.3856109882102872
GLYCOGEN STORAGE DISEASE IB	0.03687515	1.383413667291098
GLYCOGEN STORAGE DISEASE IA	0.03687515	1.383413667291098
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.036856813999999995	1.382725771160412
ALPERS-HUTTENLOCHER SYNDROME	0.036842704000000004	1.3821964182806146
PHELAN-MCDERMID SYNDROME	0.036830132999999994	1.381724802756026
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3726183575451936
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036300154	1.3618420309713077
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715	1.3617293324560056
3P25.3 MICRODELETION SYNDROME	0.03620051	1.3581037716974185
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.036178853999999996	1.357291321947957
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03604598	1.352306401001801
GALACTOSEMIA	0.035846613	1.3448269186781543
KAPOSIFORM LYMPHANGIOMATOSIS	0.03573509	1.3406430050556386
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.3398630442922796
METHANE PRODUCTION	0.035714300000000004	1.3398630442922796
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.3398630442922796
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.3398630442922796
BLUE DIAPER SYNDROME	0.035714300000000004	1.3398630442922796
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.3398630442922796
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.3398630442922796
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.3398630442922796
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.3398630442922796
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.3398630442922796
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.3398630442922796
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.3398630442922796
GASTRIC SNEEZING	0.035714300000000004	1.3398630442922796
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.3398630442922796
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.3398630442922796
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	1.3398630442922796
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.3398630442922796
TERATOMA, PINEAL	0.035714300000000004	1.3398630442922796
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
JUVENILE ABSENCE EPILEPSY	0.03566625	1.338060393273549
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.03533359999999999	1.3255806458983008
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.035220514	1.3213380945329702
%152800 LYMPHANGIECTASIA, INTESTINAL	0.03493649	1.310682607478987
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
MONOSOMY 22	0.0347755	1.30464288245286
DOORS SYNDROME	0.03461480399999999	1.298614187174901
RING CHROMOSOME 22 SYNDROME	0.034511032999999997	1.2947210987489974
FUMARASE DEFICIENCY; FMRD	0.034262054	1.2853803651799551
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.034162859999999996	1.281658988173671
ALG13-CDG	0.034162859999999996	1.281658988173671
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.278147101350292
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.278147101350292
EPILEPSY, PYRIDOXINE-DEPENDENT	0.034034004	1.2768248071191546
PIGMENTED VILLONODULAR SYNOVITIS	0.0338384	1.2694864980688372
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.033606343999999996	1.2607806503102001
CONGENITAL DISORDER OF GLYCOSYLATION	0.033579943	1.2597901864278798
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.033496859999999996	1.2566732321180112
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.033328053999999996	1.250340280861657
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.245524182591553
MYELOPEROXIDASE DEFICIENCY	0.033199679999999995	1.245524182591553
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.245524182591553
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.03314408	1.2434382846385583
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.033038423	1.2394744407533136
TYROSINEMIA TYPE 1	0.03295358	1.2362914580190338
CHROMOSOME 17Q12 DELETION SYNDROME	0.03285333	1.2325304639581032
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
AMYLOIDOSIS, FAMILIAL VISCERAL	0.03254647	1.2210182580973827
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.032456399999999996	1.217639178445831
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.032456399999999996	1.217639178445831
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0322823	1.2111076166901398
WEST SYNDROME	0.0322581	1.2101997258544837
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.03204225	1.2021018648265345
LYNCH SYNDROME	0.031791419	1.1926916513472594
FAMILIAL COLORECTAL CANCER TYPE X	0.031791419	1.1926916513472594
ACUTE INTERMITTENT PORPHYRIA	0.031791419	1.1926916513472594
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.031615733	1.1861005889772973
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0315921	1.1852139697988235
FAMILIAL ATRIAL MYXOMA	0.03157896	1.1847210075847527
22Q11.2 MICRODUPLICATION SYNDROME	0.031563133	1.1841272394750035
FOLLICULAR LYMPHOMA	0.0315193	1.1824827940618086
SHORT SYNDROME	0.03131656	1.1748767697634233
RUIJS-AALFS SYNDROME; RJALS	0.03125	1.1723796948038667
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.031135473	1.168083082666049
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.031135473	1.168083082666049
MOWAT-WILSON SYNDROME; MOWS	0.031064919	1.165436168202459
PROPIONIC ACIDEMIA	0.030820534	1.1562677838275903
TRICHOHEPATOENTERIC SYNDROME 2	0.030807429999999997	1.1557761721949276
GAUCHER DISEASE TYPE 3	0.030644029999999996	1.1496460332467369
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0305235	1.1451242116590665
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0305235	1.1451242116590665
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030498773	1.144196549812237
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.030358049999999998	1.1389171646028968
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.030315104	1.1373059960149594
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.030280143	1.1359943938866381
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.03026316	1.1353572571072188
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.03022254	1.133833351084725
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.030057663	1.1276478007826392
WHIPPLE DISEASE	0.030037899	1.12690633158942
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.030018733	1.1261872970540403
PROTOPORPHYRIA, ERYTHROPOIETIC	0.02989729	1.1216312232212062
ARIMA SYNDROME	0.029738724	1.1156824373432457
HEREDITARY SPHEROCYTOSIS	0.02972044	1.1149964920523723
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.02968256	1.113575380281519
GALLOWAY-MOWAT SYNDROME	0.029658373000000002	1.112667977155816
SOTOS SYNDROME	0.029658373000000002	1.112667977155816
ALG1-CDG	0.029658373000000002	1.112667977155816
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.02959449	1.1102713329304348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.029583473000000002	1.10985801750331
7P22.1 MICRODUPLICATION SYNDROME	0.029477313999999998	1.1058753405106478
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.029473179	1.1057202112294315
9Q33.3Q34.11 MICRODELETION SYNDROME	0.029473179	1.1057202112294315
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.1034175074442356
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.1034175074442356
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.1034175074442356
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.1034175074442356
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.1034175074442356
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.1034175074442356
MYASTHENIA GRAVIS; MG	0.0294118	1.1034175074442356
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.1034175074442356
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.1034175074442356
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.1034175074442356
MONOMELIC AMYOTROPHY	0.0294118	1.1034175074442356
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.1034175074442356
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.1034175074442356
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.1034175074442356
IMMUNE SUPPRESSION	0.0294118	1.1034175074442356
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.1034175074442356
RAGWEED SENSITIVITY	0.0294118	1.1034175074442356
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.1034175074442356
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.029271999	1.098172712125411
NIEMANN-PICK DISEASE, TYPE C2	0.029267653	1.0980096669364952
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.029267653	1.0980096669364952
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.029260454	1.0977395881709626
MENINGIOMA	0.0292549	1.0975312234725647
TETRASOMY X	0.029116954	1.0923560206124232
FETAL ALCOHOL SYNDROME	0.029116954	1.0923560206124232
PENTASOMY X	0.029116954	1.0923560206124232
CHARGE SYNDROME	0.029116954	1.0923560206124232
C SYNDROME	0.029112819	1.092200891331207
NORRIE DISEASE	0.029112819	1.092200891331207
COFS SYNDROME	0.029112819	1.092200891331207
DISTAL MONOSOMY 7Q36	0.029112819	1.092200891331207
CRI-DU-CHAT SYNDROME	0.028931759999999997	1.0854082546860389
PRADER-WILLI SYNDROME	0.028923969	1.0851159663595682
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.0718889347878144
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0718889347878144
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0718889347878144
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.0718889347878144
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0285714	1.0718889347878144
ALG12-CDG	0.0285714	1.0718889347878144
SCHWARTZ-JAMPEL SYNDROME	0.0285714	1.0718889347878144
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.0718889347878144
CHEILITIS GLANDULARIS	0.0285714	1.0718889347878144
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0718889347878144
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.0718889347878144
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0718889347878144
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0718889347878144
COG7-CDG	0.0285714	1.0718889347878144
ACRODYSOSTOSIS	0.0285714	1.0718889347878144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.028392909	1.0651926396164468
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0625832037869403
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0625832037869403
SICKLE CELL ANEMIA	0.02824334	1.059581386542139
CHROMOSOME 16P13.3 DELETION SYNDROME	0.028113973	1.0547280347348527
BOHRING-OPITZ SYNDROME	0.028113973	1.0547280347348527
RECOMBINANT 8 SYNDROME	0.028113973	1.0547280347348527
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0511792695357942
PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0511792695357942
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.027991733	1.0501420605302825
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.027847913000000002	1.0447464878036683
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623313
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623313
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623313
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623313
CAMPOMELIA, CUMMING TYPE	0.02774008	1.040701008775515
HEMORRHAGIC FEVER-RENAL SYNDROME	0.027608459999999998	1.0357631330817523
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.034260948910244
LINEAR VERRUCOUS NEVUS SYNDROME	0.027568419	1.034260948910244
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.027374939999999997	1.0270023616791732
NIEMANN-PICK DISEASE, TYPE A	0.027249134	1.0222826048828695
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.02720447	1.0206069835488305
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027193483999999997	1.0201948311223625
LEGIONELLOSIS	0.027148459999999996	1.0185057039742393
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.02706593	1.0154094960954503
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	1.0139489923668514
BARDET-BIEDL SYNDROME 12; BBS12	0.027027	1.0139489923668514
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
LIPOSARCOMA	0.027027	1.0139489923668514
POLYARTERITIS NODOSA	0.027027	1.0139489923668514
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
INFANTILE MYOFIBROMATOSIS	0.027027	1.0139489923668514
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.027027	1.0139489923668514
NIPPLES, SUPERNUMERARY	0.027027	1.0139489923668514
WAARDENBURG SYNDROME TYPE 2	0.027027	1.0139489923668514
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02690476	1.009363018162281
FAMILIAL MEDITERRANEAN FEVER	0.026857219	1.0075794628640196
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.026769354	1.0042831063237334
14Q12 MICRODELETION SYNDROME	0.026765219	1.004127977042517
NEONATAL LUPUS ERYTHEMATOSUS	0.02676094	1.0039674454356668
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.02665715	1.0000736442029086
OCULOCEREBRORENAL SYNDROME OF LOWE	0.026547409	0.9959565843601097
HEMOGLOBIN--BETA LOCUS	0.02653976	0.9956696233269718
GLYCOGEN STORAGE DISEASE VII	0.02653976	0.9956696233269718
SPHEROCYTOSIS, TYPE 1; SPH1	0.02653976	0.9956696233269718
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.02653976	0.9956696233269718
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.026501069999999998	0.994218123474429
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02647668	0.9933031045702286
HUGHES-STOVIN SYNDROME	0.0263158	0.9872675063206271
MALIGNANT PERITONEAL MESOTHELIOMA	0.0263158	0.9872675063206271
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0263158	0.9872675063206271
LIPEDEMA	0.0263158	0.9872675063206271
FIBRONECTIN GLOMERULOPATHY	0.0263158	0.9872675063206271
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.0263158	0.9872675063206271
OSTEOSCLEROSIS-ICHTHYOSIS-PREMATURE OVARIAN FAILURE SYNDROME	0.0263158	0.9872675063206271
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.026285143	0.9861173737029119
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02627305	0.9856636908981354
OCCIPITAL HORN SYNDROME	0.026216913999999997	0.983557684288615
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.026212779	0.9834025550073986
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.02601249	0.9758884827932364
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02586209	0.9702460537980844
20Q11.2 MICRODUPLICATION SYNDROME	0.025719033	0.9648791058940984
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.025719033	0.9648791058940984
22Q11.2 DELETION SYNDROME	0.025642263000000002	0.9619989910406557
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.025545554	0.9583708416677025
PEROXISOME BIOGENESIS DISORDER 10B	0.025545554	0.9583708416677025
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9582157123864861
ACUTE BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9582157123864861
MENKES DISEASE	0.025541419000000003	0.9582157123864861
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.025541419000000003	0.9582157123864861
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.025509689999999998	0.95702536245572
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.025314519	0.949703297898454
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.025173479	0.9444120200694895
CRIGLER-NAJJAR SYNDROME TYPE 2	0.025	0.9379037558430935
GALACTOKINASE DEFICIENCY	0.025	0.9379037558430935
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.025	0.9379037558430935
FARBER DISEASE	0.024976434	0.9370196502466853
MIXED CONNECTIVE TISSUE DISEASE	0.024972299	0.9368645209654689
PORTAL HYPERTENSION, NONCIRRHOTIC	0.02495938	0.9363798498205995
POLYCYTHEMIA VERA	0.02495938	0.9363798498205995
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.02489935	0.9341277553220692
MILLER-DIEKER SYNDROME	0.024745819	0.9283678632605352
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0247329	0.9278831921156657
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.927782423736138
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.02455529	0.9212199486726542
CRANIOFACIOFRONTODIGITAL SYNDROME	0.02443088	0.9165525644220764
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.02443088	0.9165525644220764
JUVENILE IDIOPATHIC ARTHRITIS	0.02443088	0.9165525644220764
PACHYDERMOPERIOSTOSIS	0.02443088	0.9165525644220764
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.02443088	0.9165525644220764
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.024417964	0.9160680058256577
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.024417963999999997	0.9160680058256577
CHRONIC GRAFT VERSUS HOST DISEASE	0.024329769999999997	0.9127593064719447
DIGEORGE SYNDROME; DGS	0.024268333	0.9104544267500354
RHOMBENCEPHALOSYNAPSIS	0.024204399999999997	0.9080559067171426
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.02419608	0.907743772347198
PEHO-LIKE SYNDROME; PEHOL	0.024157044	0.9062792919066747
SALT-AND-PEPPER SYNDROME	0.024055703999999997	0.9024774052419889
AA AMYLOIDOSIS	0.02392578	0.8976031569390227
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.023814273	0.893419843574911
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.023814273	0.893419843574911
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.023814273	0.893419843574911
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.023814273	0.893419843574911
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.023814273	0.893419843574911
X-LINKED AGAMMAGLOBULINEMIA	0.02368689	0.8886409238096884
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.023666589999999998	0.8878793459599438
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.023666589999999998	0.8878793459599438
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.023666589999999998	0.8878793459599438
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.023666589999999998	0.8878793459599438
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.02354609	0.88335864985678
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02354609	0.88335864985678
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.023459443000000003	0.8801079879874787
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8795567631920945
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.023295119	0.8739431841164722
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.023272854	0.8731078870315184
OPTIC ATROPHY 11; OPA11	0.023272854	0.8731078870315184
FETAL HYDANTOIN SYNDROME	0.023272854	0.8731078870315184
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.023272854	0.8731078870315184
COWDEN SYNDROME 5; CWS5	0.023268719	0.872952757750302
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.023268719	0.872952757750302
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.872952757750302
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.023268719	0.872952757750302
COWDEN SYNDROME 6; CWS6	0.023268719	0.872952757750302
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.023268719	0.872952757750302
WILLIAMS-BEUREN SYNDROME; WBS	0.0232558	0.8724680866054324
NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER	0.0232558	0.8724680866054324
CYSTINOSIS	0.0232558	0.8724680866054324
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.02309757	0.8665319061539504
AICARDI-GOUTIERES SYNDROME 5	0.023055044	0.8649364943491111
ISOLATED COMPLEX I DEFICIENCY	0.022957034	0.8612595364647039
CEREBROTENDINOUS XANTHOMATOSIS	0.022763619000000002	0.8540033502672483
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069095
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069095
POPLITEAL CYST	0.0227273	0.8526408012069095
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.8526408012069095
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0227273	0.8526408012069095
WATSON SYNDROME	0.0227273	0.8526408012069095
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069095
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069095
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0227273	0.8526408012069095
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069095
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	0.8526408012069095
FACIOSCAPULOHUMERAL DYSTROPHY	0.0227273	0.8526408012069095
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069095
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069095
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.0227273	0.8526408012069095
SILVER-RUSSELL SYNDROME	0.0227273	0.8526408012069095
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069095
BETHLEM MYOPATHY 1	0.0227273	0.8526408012069095
LARSEN SYNDROME	0.0227273	0.8526408012069095
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.0227273	0.8526408012069095
THYMIC TUMOR	0.0227273	0.8526408012069095
GAPO SYNDROME	0.0227273	0.8526408012069095
THYMIC CARCINOMA	0.0227273	0.8526408012069095
OSTEOSARCOMA	0.0227273	0.8526408012069095
LYME DISEASE	0.0227273	0.8526408012069095
MACS SYNDROME	0.0227273	0.8526408012069095
OSTEOCHONDRITIS DISSECANS	0.0227273	0.8526408012069095
FATCO SYNDROME	0.0227273	0.8526408012069095
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8526408012069095
REACTIVE ARTHRITIS	0.0227273	0.8526408012069095
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.8526408012069095
FAMILIAL AFIBRINOGENEMIA	0.0227273	0.8526408012069095
HEMOPHILIA A	0.0227273	0.8526408012069095
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8526408012069095
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0227273	0.8526408012069095
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.8526408012069095
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.8526408012069095
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8526408012069095
PANNER DISEASE	0.0227273	0.8526408012069095
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8526408012069095
SINDING-LARSEN-JOHANSSON DISEASE	0.0227273	0.8526408012069095
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069095
CRANIO-OSTEOARTHROPATHY	0.0227273	0.8526408012069095
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069095
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8526408012069095
JUVENILE DERMATOMYOSITIS	0.0227273	0.8526408012069095
SEVERE HEMOPHILIA A	0.0227273	0.8526408012069095
SIRENOMELIA	0.0227273	0.8526408012069095
ALKAPTONURIA	0.0227273	0.8526408012069095
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069095
ENTHESITIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069095
THUMB DEFORMITY	0.0227273	0.8526408012069095
NAIL-PATELLA SYNDROME	0.0227273	0.8526408012069095
ATAXIA-PANCYTOPENIA SYNDROME	0.02261289	0.8483485784586692
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.022578604	0.8470622997317557
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064701
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064701
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.022440573000000002	0.8418839079988447
BEHÇET DISEASE	0.022426718999999998	0.8413641592535066
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.022325933	0.8375830565360504
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.022324224	0.837518941435301
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.022312959999999996	0.8370963595190681
SECONDARY SHORT BOWEL SYNDROME	0.0222222	0.8336913937238557
PLEURAL MESOTHELIOMA	0.022111779999999998	0.8295488604150478
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.021899154	0.8215719514554523
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.021895019	0.8214168221742358
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.02180921	0.8181975988388299
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.021794873	0.8176597297929291
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.021794873	0.8176597297929291
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.021794873	0.8176597297929291
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.021794873	0.8176597297929291
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.021681113999999998	0.813391930058491
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.02164498	0.8120363214859457
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02151033	0.8069847718569747
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.021493459000000003	0.8063518368863817
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299114	0.7990607606692086
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7985839303997377
PANCREATIC COLIPASE DEFICIENCY	0.0212766	0.7982161220628465
MYOTONIC DYSTROPHY 1	0.0212766	0.7982161220628465
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.021249319	0.7971926439683202
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.021135559999999998	0.792924844233882
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870419
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870419
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870419
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870419
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870419
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.02095204	0.7860398803429891
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.020949619	0.7859490537432732
MYASTHENIA GRAVIS	0.020949619	0.7859490537432732
MALIGNANT ATROPHIC PAPULOSIS	0.020949619	0.7859490537432732
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.020949619	0.7859490537432732
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.020848833	0.7821679510258173
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.020707899999999998	0.7768806874249277
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.020707899999999998	0.7768806874249277
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.020647653000000002	0.7746204519217967
LETTERER-SIWE DISEASE	0.020590050000000002	0.7724594091198835
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.020450363000000003	0.7672188906421853
FETAL GAUCHER DISEASE	0.020449088999999997	0.7671710950667874
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.020441309999999997	0.7668792569341193
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.020421173	0.7661237942168629
MULTIPLE MYELOMA	0.020408199999999998	0.7656370971998807
HEPATITIS B VACCINE, RESPONSE TO	0.020408199999999998	0.7656370971998807
OVARIAN FIBROTHECOMA	0.020408199999999998	0.7656370971998807
PANCREATITIS, HEREDITARY	0.020408199999999998	0.7656370971998807
NOONAN SYNDROME 8; NS8	0.020408199999999998	0.7656370971998807
ADENOCARCINOMA OF OVARY	0.020408199999999998	0.7656370971998807
RELAPSING POLYCHONDRITIS	0.020408199999999998	0.7656370971998807
OVARIAN FIBROMA	0.020408199999999998	0.7656370971998807
AUTOSOMAL AGAMMAGLOBULINEMIA	0.020408199999999998	0.7656370971998807
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.020408199999999998	0.7656370971998807
PRIMARY EFFUSION LYMPHOMA	0.020408199999999998	0.7656370971998807
LICHEN PLANOPILARIS	0.020408199999999998	0.7656370971998807
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.020408199999999998	0.7656370971998807
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.020317773	0.7622446242826959
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.020317773	0.7622446242826959
GABRIELE-DE VRIES SYNDROME; GADEVS	0.020307414	0.7618559944824246
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.020307414	0.7618559944824246
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.020188559999999998	0.7573970499625455
COG5-CDG	0.020119529000000004	0.7548072725957616
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.01994539	0.7482742477102111
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.01990767	0.746859138523395
PEROXISOME BIOGENESIS DISORDER 6B	0.019879754	0.7458118376734704
RIDDLE SYNDROME	0.019879754	0.7458118376734704
OCULODENTODIGITAL DYSPLASIA; ODDD	0.019875619	0.745656708392254
MEGALENCEPHALY WITH DYSMYELINATION	0.019875619	0.745656708392254
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.019875433	0.7456497303883105
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.019835818999999998	0.7441635656129516
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.019776354	0.7419326677393033
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.019772219	0.7417775384580869
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.019772219	0.7417775384580869
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.019772219	0.7417775384580869
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.019772219	0.7417775384580869
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.019772219	0.7417775384580869
49,XYYYY SYNDROME	0.01976186	0.7413889086578158
49,XXXYY SYNDROME	0.01976186	0.7413889086578158
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01974502	0.7407571366878798
ACQUIRED GENERALIZED LIPODYSTROPHY	0.01974502	0.7407571366878798
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.019392523999999998	0.7275328437950931
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0193342	0.7253447518488615
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0193342	0.7253447518488615
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.019334014000000004	0.7253377738449182
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.019248460000000002	0.722128117127822
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.0192308	0.7214655819146945
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0192308	0.7214655819146945
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0192308	0.7214655819146945
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0192308	0.7214655819146945
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.0192308	0.7214655819146945
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0192308	0.7214655819146945
FREE SIALIC ACID STORAGE DISEASE	0.019193052999999998	0.720049459791822
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.019076074	0.7156608580536312
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.018989544	0.7124145855739071
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.01894498	0.7107427158548915
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7107086887066296
HAREL-YOON SYNDROME; HAYOS	0.018852814	0.7072850023524502
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.018823390000000002	0.7061811271479731
JOUBERT SYNDROME 1	0.018689354	0.7011526124352456
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018402654	0.6903967321632372
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.018402654	0.6903967321632372
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6903967321632372
ADRENOLEUKODYSTROPHY	0.018398519000000002	0.6902416028820207
CHROMOSOME 18Q DELETION SYNDROME	0.018398519000000002	0.6902416028820207
JUVENILE HUNTINGTON DISEASE	0.018398519000000002	0.6902416028820207
MERCURY POISONING	0.018398519000000002	0.6902416028820207
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.01837028	0.6891821843155704
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.01837028	0.6891821843155704
PERMANENT NEONATAL DIABETES MELLITUS	0.018324164	0.6874520895313921
PRIMARY LIPODYSTROPHY	0.01804144	0.6768453734727127
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.018032034	0.6764924965636143
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01800509	0.675481661411717
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	0.6699296463386282
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6699296463386282
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	0.6699296463386282
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	0.6699296463386282
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6699296463386282
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0178571	0.6699296463386282
SPASTIC PARAPLEGIA TYPE 7	0.0178571	0.6699296463386282
19P13.3 MICRODUPLICATION SYNDROME	0.017740653999999998	0.6655610407085119
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017740653999999998	0.6655610407085119
INFANTILE SIALIC ACID STORAGE DISEASE	0.017715953	0.6646343542815888
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.017621879	0.6611050599645014
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.017535013	0.6578461820582987
PYRIDOXINE-DEPENDENT EPILEPSY	0.017531314	0.6577074098185842
HYPERLIPOPROTEINEMIA, TYPE I	0.01731136	0.6494555825100757
RETICULOENDOTHELIOSIS, X-LINKED	0.01731136	0.6494555825100757
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
MOSAIC TRISOMY 15	0.0172414	0.6468309526397245
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
NEPHRONOPHTHISIS 11; NPHP11	0.017212254	0.6457375069250123
FADD-RELATED IMMUNODEFICIENCY	0.017208119	0.6455823776437959
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.017195099999999998	0.6450939548839029
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.017030470000000002	0.6389176710709252
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6320369840211588
PORPHYRIA CUTANEA TARDA, TYPE I	0.0166667	0.6252704211004034
BARDET-BIEDL SYNDROME	0.0166667	0.6252704211004034
HB BART'S HYDROPS FETALIS	0.016628979999999998	0.6238553119135873
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.016628979999999998	0.6238553119135873
KLIPPEL-TRÉNAUNAY SYNDROME	0.016628979999999998	0.6238553119135873
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6153586542086534
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6153586542086534
PREECLAMPSIA/ECLAMPSIA 1	0.016362369	0.613853093583624
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
CHÉDIAK-HIGASHI SYNDROME	0.016167032999999997	0.6065248388615693
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.016148913999999997	0.6058450837354844
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016148913999999997	0.6058450837354844
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.016148913999999997	0.6058450837354844
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016148913999999997	0.6058450837354844
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.016148913999999997	0.6058450837354844
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01609337	0.6037612866869025
INFANTILE LIVER FAILURE SYNDROME 1	0.016057913	0.6024310765480654
HYPERPROLINEMIA, TYPE I	0.015963132999999997	0.5988752958289131
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.015836080000000002	0.5941087563932679
CHOLESTERYL ESTER STORAGE DISEASE	0.015662389999999998	0.5875925762591722
REYNOLDS SYNDROME	0.015662389999999998	0.5875925762591722
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.015632842999999997	0.5864840865682164
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015603359999999998	0.5853779979108755
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.015603359999999998	0.5853779979108755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015536353999999999	0.5828641907483146
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.015536353999999999	0.5828641907483146
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015536353999999999	0.5828641907483146
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.015536353999999999	0.5828641907483146
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.015536353999999999	0.5828641907483146
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.015512359	0.5819639907234565
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.015512358999999998	0.5819639907234564
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230291
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230291
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230291
TRISOMY 13	0.015466818999999998	0.5802555052418126
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.015421714	0.5785633392855206
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.015421714	0.5785633392855206
TANGIER DISEASE	0.015326890000000003	0.5750059078557581
CONGENITAL TOXOPLASMOSIS	0.015253973	0.5722703427291655
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5693338411019213
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.015175699999999999	0.5693338411019213
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.014990799999999999	0.5623971049237058
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.014990799999999999	0.5623971049237058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.014990799999999999	0.5623971049237058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.014990799999999999	0.5623971049237058
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.014990799999999999	0.5623971049237058
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.014970939999999999	0.5616520341800639
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.014970939999999999	0.5616520341800639
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.014970939999999999	0.5616520341800639
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.014925399999999998	0.5599435486984202
ACHONDROGENESIS TYPE 1B	0.014925399999999998	0.5599435486984202
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.014925399999999998	0.5599435486984202
ACHONDROGENESIS	0.014925399999999998	0.5599435486984202
PHOCOMELIA, SCHINZEL TYPE	0.014925399999999998	0.5599435486984202
YUNIS-VARON SYNDROME	0.014925399999999998	0.5599435486984202
INDOMETHACIN EMBRYOFETOPATHY	0.014925399999999998	0.5599435486984202
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.014925399999999998	0.5599435486984202
ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	0.014925399999999998	0.5599435486984202
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.014925399999999998	0.5599435486984202
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.014925399999999998	0.5599435486984202
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27	0.014925399999999998	0.5599435486984202
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.014925399999999998	0.5599435486984202
FIBROCHONDROGENESIS 1; FBCG1	0.014925399999999998	0.5599435486984202
ACHONDROGENESIS TYPE 1A	0.014925399999999998	0.5599435486984202
BOOMERANG DYSPLASIA	0.014925399999999998	0.5599435486984202
ACHONDROGENESIS TYPE 2	0.014925399999999998	0.5599435486984202
FRASER SYNDROME 3; FRASRS3	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
PEDIATRIC-ONSET GRAVES DISEASE	0.014712554	0.5519583861857731
RETINITIS PIGMENTOSA 71; RP71	0.01444702	0.5419965727496115
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.014354333	0.5385193133328983
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.014320799999999998	0.5372612842671108
HEMOCHROMATOSIS, TYPE 2B	0.014320799999999998	0.5372612842671108
HURLER SYNDROME	0.014297334000000002	0.5363809302857264
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.5343858214162969
AYMÉ-GRIPP SYNDROME	0.014244153999999998	0.5343858214162969
DYSKERATOSIS CONGENITA	0.014223474	0.5336099874294634
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.013996993999999999	0.5251133297245297
WRINKLY SKIN SYNDROME	0.013944614	0.5231482337752873
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.013901653	0.5215365024450963
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.013812913999999999	0.5182073567895059
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.013808779	0.5180522275082895
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.013751780000000002	0.5159138444611175
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.013751780000000002	0.5159138444611175
PERLMAN SYNDROME	0.013743433999999999	0.5156007346712667
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
SEA-BLUE HISTIOCYTOSIS	0.01360296	0.5103306909833347
MONOSOMY 18P	0.013561414	0.5087720450057244
SANDHOFF DISEASE	0.013525300000000002	0.5074171867561837
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.013525300000000002	0.5074171867561837
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516954	0.507104076966333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516953999999998	0.507104076966333
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516953999999998	0.507104076966333
CRONKHITE-CANADA SYNDROME	0.013356099	0.5010694166204873
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013301314000000002	0.4990140943299329
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.013301314000000002	0.4990140943299329
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.013301314000000002	0.4990140943299329
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.013267359999999999	0.4977402709648969
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.013267359999999999	0.4977402709648969
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.013204163000000001	0.49536936281857635
CEREBROFACIOARTICULAR SYNDROME	0.013133754000000001	0.49272788819677016
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.013083679	0.49084926697381637
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.013027312999999999	0.4887346316497422
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.4866369911417241
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01281468	0.48075746007709486
HEMOCHROMATOSIS, TYPE 3; HFE3	0.012617219999999998	0.4733495210519438
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.4720009279994921
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01254226	0.47053731043042385
CHANARIN-DORFMAN SYNDROME	0.01252647	0.4699449304182334
MARBURG HEMORRHAGIC FEVER	0.01246342	0.46757953714599704
RELAPSING FEVER	0.01246342	0.46757953714599704
BETA-KETOTHIOLASE DEFICIENCY	0.012342789	0.46305392642715276
19P13.12 MICRODELETION SYNDROME	0.012337523	0.4628563663800219
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.012198073	0.45762473922992924
OCULOECTODERMAL SYNDROME; OES	0.012198073	0.45762473922992924
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.012198073	0.45762473922992924
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.012136342999999999	0.4553088672760014
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.012048200000000002	0.45200208124595037
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.012048200000000002	0.45200208124595037
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.012048200000000002	0.45200208124595037
NEUTROPHILIA, HEREDITARY	0.012048200000000002	0.45200208124595037
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.012048200000000002	0.45200208124595037
ROIFMAN SYNDROME	0.012048200000000002	0.45200208124595037
INTERMEDIATE OSTEOPETROSIS	0.012048200000000002	0.45200208124595037
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.012048200000000002	0.45200208124595037
BENT BONE DYSPLASIA SYNDROME; BBDS	0.012048200000000002	0.45200208124595037
FGFR2-RELATED BENT BONE DYSPLASIA	0.012048200000000002	0.45200208124595037
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.012048200000000002	0.45200208124595037
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.012048200000000002	0.45200208124595037
COG1-CDG	0.012048200000000002	0.45200208124595037
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.012048200000000002	0.45200208124595037
ACROCEPHALOPOLYDACTYLY	0.012048200000000002	0.45200208124595037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4516889714560996
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.4516889714560996
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012039854	0.4516889714560996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4516889714560996
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4516889714560996
RING CHROMOSOME 14 SYNDROME	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.4516889714560996
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.4516889714560996
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012039854	0.4516889714560996
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.4516889714560996
SEA-BLUE HISTIOCYTE DISEASE	0.01197434	0.4492311383896875
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011823333	0.4435659370913436
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.011709574	0.43929813735690537
GERMAN SYNDROME	0.011656654	0.4373127826865368
CARDIOFACIOCUTANEOUS SYNDROME	0.011656654	0.4373127826865368
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.011656654	0.4373127826865368
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.011656654	0.4373127826865368
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.011652519	0.4371576534053203
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.011652519	0.4371576534053203
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.011652519	0.4371576534053203
FABRY DISEASE	0.011652519	0.4371576534053203
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.011652519	0.4371576534053203
PROTEUS SYNDROME	0.011652519	0.4371576534053203
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011612423	0.4356534058455489
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
DESMOSTEROLOSIS	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011429729	0.428799430294749
WOLCOTT-RALLISON SYNDROME	0.011429729	0.428799430294749
BIOTINIDASE DEFICIENCY	0.011281914	0.4232539805479511
KRABBE DISEASE	0.011281914	0.4232539805479511
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.011281914	0.4232539805479511
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.4230988512667347
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.4230988512667347
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011184763	0.4196092490365946
XQ12-Q13.3 DUPLICATION SYNDROME	0.01116402	0.41883105153229644
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0111111	0.41684569686192785
TERMINAL TRANSVERSE LIMB DEFECT	0.0111111	0.41684569686192785
INFANTILE SYSTEMIC HYALINOSIS	0.0111111	0.41684569686192785
DOHLE BODIES AND LEUKEMIA	0.0111111	0.41684569686192785
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0111111	0.41684569686192785
CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	0.0111111	0.41684569686192785
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0111111	0.41684569686192785
ALG8-CDG	0.0111111	0.41684569686192785
GREENBERG DYSPLASIA	0.0111111	0.41684569686192785
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0111111	0.41684569686192785
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0111111	0.41684569686192785
SCHNECKENBECKEN DYSPLASIA	0.0111111	0.41684569686192785
MELORHEOSTOSIS	0.0111111	0.41684569686192785
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0111111	0.41684569686192785
BUSCHKE-OLLENDORFF SYNDROME	0.0111111	0.41684569686192785
LYMPHEDEMA, HEREDITARY, IB	0.0111111	0.41684569686192785
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0111111	0.41684569686192785
CHYLOUS ASCITES	0.0111111	0.41684569686192785
GERMAN SYNDROME	0.0111111	0.41684569686192785
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0111111	0.41684569686192785
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.0111111	0.41684569686192785
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0111111	0.41684569686192785
CLAPO SYNDROME	0.0111111	0.41684569686192785
IDIOPATHIC STEROID-SENSITIVE NEPHROTIC SYNDROME	0.0111111	0.41684569686192785
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0111111	0.41684569686192785
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0111111	0.41684569686192785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.011084304	0.41584041410026495
NOONAN SYNDROME 6; NS6	0.011071004	0.4153414493021565
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.01104937	0.414529824908
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.01104937	0.414529824908
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01104937	0.414529824908
DYSBETALIPOPROTEINEMIA	0.01104937	0.414529824908
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.01104937	0.414529824908
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01104937	0.414529824908
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.414529824908
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.414529824908
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.414529824908
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.010969663999999999	0.4115395626374708
GAUCHER DISEASE TYPE 2	0.01096284	0.4112835524282759
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01096284	0.4112835524282759
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01088831	0.40848747375135647
HEPATIC VENO-OCCLUSIVE DISEASE	0.01088831	0.40848747375135647
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01088831	0.40848747375135647
CINCA SYNDROME	0.010869824	0.4077939501981359
PELGER-HUET ANOMALY; PHA	0.010866494	0.4076690214178576
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075843
CONGENITAL RUBELLA SYNDROME	0.010786849000000001	0.4046810476324927
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.4027868947233422
MERRF	0.01073636	0.4027868947233422
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.010643343999999999	0.39929729249320206
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01053875	0.395373328275656
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01053875	0.395373328275656
OLIVER SYNDROME	0.01053875	0.395373328275656
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.010432763	0.39139710406083433
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.010432763	0.39139710406083433
HEMOCHROMATOSIS, TYPE 2A	0.010399229999999999	0.39013907499504685
GALACTOSEMIA	0.010399229999999999	0.39013907499504685
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.010399229999999999	0.39013907499504685
CLASSIC MYCOSIS FUNGOIDES	0.01032427	0.387326864373527
MAJEED SYNDROME	0.01032427	0.387326864373527
PLAGUE	0.01032427	0.387326864373527
SÉZARY SYNDROME	0.01032427	0.387326864373527
NODULAR NON-SUPPURATIVE PANNICULITIS	0.01032427	0.387326864373527
OMENN SYNDROME	0.01032427	0.387326864373527
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.010271703	0.3853547529041908
BABESIOSIS	0.01024543	0.38436909108910017
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.009982142999999999	0.3744915764425137
MONOSOMY 13Q34	0.009891344	0.37108514751744187
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.009891344	0.37108514751744187
ADRENOMYODYSTROPHY	0.009887209	0.3709300182362254
ACQUIRED PARTIAL LIPODYSTROPHY	0.009887209	0.3709300182362254
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3678388750377178
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3678388750377178
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3678388750377178
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3678388750377178
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3678388750377178
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.3678388750377178
INFANTILE LIVER FAILURE SYNDROME 2	0.009726149	0.36488766707958187
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009707663	0.36419414352636126
AICARDI-GOUTIERES SYNDROME 7	0.009565743	0.3588698514851912
NIEMANN-PICK DISEASE TYPE C	0.009530812999999999	0.3575594123575272
1Q44 MICRODELETION SYNDROME	0.009492564	0.3561244571272375
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.009492564	0.3561244571272375
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.009449394	0.35450488492164767
PSEUDO-TORCH SYNDROME 2	0.009445259000000001	0.3543497556404313
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.009445259000000001	0.3543497556404313
GALACTOSE EPIMERASE DEFICIENCY	0.009417054	0.35329161262308906
PATENT DUCTUS VENOSUS	0.00934579	0.35061806169283294
%613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	0.00934579	0.35061806169283294
AROMATASE DEFICIENCY	0.00934579	0.35061806169283294
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00934579	0.35061806169283294
%613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED	0.00934579	0.35061806169283294
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00934579	0.35061806169283294
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00934579	0.35061806169283294
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00934579	0.35061806169283294
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00934579	0.35061806169283294
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.00934579	0.35061806169283294
ATYPICAL WERNER SYNDROME	0.00934579	0.35061806169283294
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.009302899	0.34900895649315833
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
CARNOSINEMIA	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310885
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
PAINE SYNDROME	0.00925926	0.34737178921310885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.009241204	0.34669439760448867
SCLERODERMA	0.009237068999999999	0.34653926832327225
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.009166244	0.3438821869829688
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.009166244	0.3438821869829688
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.009166244	0.3438821869829688
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.009162109	0.3437270577017524
FAMILIAL MULTIPLE NEVI FLAMMEI	0.009162109	0.3437270577017524
SYSTEMIC SCLEROSIS	0.009162109	0.3437270577017524
PAPILLORENAL SYNDROME	0.009162109	0.3437270577017524
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009162109	0.3437270577017524
SARCOSINEMIA	0.009064904	0.34008030031828324
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.009064904	0.34008030031828324
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00894701	0.3356573713026286
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00894701	0.3356573713026286
LEISHMANIASIS	0.00890384	0.3340377990970388
AMISH LETHAL MICROCEPHALY	0.00874583	0.32810987219860804
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00874583	0.32810987219860804
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.00869565	0.32622731177987974
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.00869565	0.32622731177987974
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00869565	0.32622731177987974
CRANIOECTODERMAL DYSPLASIA 3	0.00869565	0.32622731177987974
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.00869565	0.32622731177987974
LETHAL KNIEST-LIKE DYSPLASIA	0.00862069	0.32341510115835986
BAZEX SYNDROME	0.00862069	0.32341510115835986
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00862069	0.32341510115835986
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00862069	0.32341510115835986
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00862069	0.32341510115835986
SAPHO SYNDROME	0.00862069	0.32341510115835986
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.00862069	0.32341510115835986
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00862069	0.32341510115835986
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00862069	0.32341510115835986
JOHANSON-BLIZZARD SYNDROME	0.00862069	0.32341510115835986
OPSISMODYSPLASIA; OPSMD	0.00862069	0.32341510115835986
WHITE SPONGE NEVUS 2; WSN2	0.00862069	0.32341510115835986
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00862069	0.32341510115835986
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00862069	0.32341510115835986
THORACIC OUTLET SYNDROME	0.00862069	0.32341510115835986
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00862069	0.32341510115835986
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00862069	0.32341510115835986
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.00862069	0.32341510115835986
ANEURYSM OF SINUS OF VALSALVA	0.00862069	0.32341510115835986
KNIEST-LIKE DYSPLASIA, LETHAL	0.00862069	0.32341510115835986
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00862069	0.32341510115835986
EOSINOPHILIC GASTROENTERITIS	0.00862069	0.32341510115835986
CHILBLAIN LUPUS 2; CHBL2	0.00862069	0.32341510115835986
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.00862069	0.32341510115835986
LIPEDEMA	0.00862069	0.32341510115835986
MASTOCYTOSIS, CUTANEOUS; MASTC	0.00862069	0.32341510115835986
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00862069	0.32341510115835986
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.00862069	0.32341510115835986
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00862069	0.32341510115835986
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00862069	0.32341510115835986
EOSINOPHILIC ESOPHAGITIS	0.00862069	0.32341510115835986
SUPERFICIAL EPIDERMOLYTIC ICHTHYOSIS	0.00862069	0.32341510115835986
THYMIC EPITHELIAL NEOPLASM	0.00862069	0.32341510115835986
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00862069	0.32341510115835986
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00862069	0.32341510115835986
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.00862069	0.32341510115835986
CLUSTER HEADACHE, FAMILIAL	0.00862069	0.32341510115835986
PIERSON SYNDROME	0.00862069	0.32341510115835986
DERMATITIS HERPETIFORMIS	0.00862069	0.32341510115835986
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00862069	0.32341510115835986
DISSECTING CELLULITIS OF THE SCALP	0.00862069	0.32341510115835986
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.00862069	0.32341510115835986
WELLS SYNDROME	0.00862069	0.32341510115835986
NK-CELL ENTEROPATHY	0.00862069	0.32341510115835986
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00862069	0.32341510115835986
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00862069	0.32341510115835986
ANTISYNTHETASE SYNDROME	0.00862069	0.32341510115835986
MELAS	0.00851935	0.3196132144936743
SALLA DISEASE	0.008256713	0.30976008534473987
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.008189222999999999	0.30722812036546576
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.007965333	0.2988286294896374
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.007963624	0.29876451438888796
PITT-HOPKINS-LIKE SYNDROME	0.007959489	0.29860938510767154
ASPARTYLGLUCOSAMINURIA; AGU	0.007937639	0.2977896572250646
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.007862163	0.2949580882700241
CHOREOACANTHOCYTOSIS	0.0076436690000000005	0.2867610345408569
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0076436690000000005	0.2867610345408569
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.2846651948080499
X SMALL RINGS	0.007587804	0.2846651948080499
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2846651948080499
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.2846651948080499
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2846651948080499
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2846651948080499
W SYNDROME	0.007587804	0.2846651948080499
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.007546342999999999	0.2831097377032094
GALACTOSE EPIMERASE DEFICIENCY	0.007512294	0.2818323503039014
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.007508159	0.281677221022685
HEREDITARY FRUCTOSE INTOLERANCE	0.007508159	0.281677221022685
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.007508159	0.281677221022685
ZELLWEGER SYNDROME	0.007508159	0.281677221022685
21Q22.11Q22.12 MICRODELETION SYNDROME	0.007316609	0.2744910024454152
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.007316609	0.2744910024454152
TOXIC EPIDERMAL NECROLYSIS	0.00720026	0.2701260358818717
STEVENS-JOHNSON SYNDROME	0.00720026	0.2701260358818717
NEUROLEPTIC MALIGNANT SYNDROME	0.00720026	0.2701260358818717
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00716792	0.26891276358331306
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.264198108983441
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.264198108983441
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.264198108983441
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00696674	0.2613652644792925
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00696674	0.2613652644792925
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.00696674	0.2613652644792925
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00696674	0.2613652644792925
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006779613	0.2543449798345065
EMANUEL SYNDROME	0.006779613	0.2543449798345065
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.006779613	0.2543449798345065
CHROMOSOME 10Q26 DELETION SYNDROME	0.006779613	0.2543449798345065
CLASSIC GALACTOSEMIA	0.00674026	0.25286860677435874
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006712123	0.2518130148552325
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.006712123	0.2518130148552325
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0066605499999999995	0.2498781944392286
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.006578433	0.2467974807304859
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.006578433	0.2467974807304859
CHROMOSOME 16P13.2 DELETION SYNDROME	0.006488233000000001	0.2434135239794041
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006488233000000001	0.2434135239794041
PIERPONT SYNDROME	0.006488233000000001	0.2434135239794041
ALG11-CDG	0.006485643	0.24331635715029873
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.006485643	0.24331635715029873
SRD5A3-CDG	0.006485643	0.24331635715029873
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0063519530000000005	0.2383008230255522
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0063519530000000005	0.2383008230255522
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006166569	0.23134592903062356
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.006166569	0.23134592903062356
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.006166569	0.23134592903062356
CLASSIC HOMOCYSTINURIA	0.006166569	0.23134592903062356
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006166569	0.23134592903062356
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.006069243	0.22769463219297617
METHYLMALONIC ACIDURIA, CBLA TYPE	0.006069243	0.22769463219297617
PROPIONIC ACIDEMIA	0.006069243	0.22769463219297617
GAUCHER DISEASE, TYPE II	0.006069243	0.22769463219297617
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0060605730000000005	0.22736936717044978
MENTAL RETARDATION, X-LINKED 104; MRX104	0.006060573	0.22736936717044973
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.006060573	0.22736936717044973
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.006060573	0.22736936717044973
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006060573	0.22736936717044973
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.006060573	0.22736936717044973
CHROMOSOME 1P35 DELETION SYNDROME	0.006060573	0.22736936717044973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.006060573	0.22736936717044973
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006060573	0.22736936717044973
GAPO SYNDROME; GAPOS	0.006032879	0.22633039490587703
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.005946814000000001	0.22310156743601162
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.005942679000000001	0.22294643815479517
ATAXIA-TELANGIECTASIA	0.005940089	0.2228492713256898
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.005940089	0.2228492713256898
OROFACIODIGITAL SYNDROME TYPE 1	0.005940089	0.2228492713256898
COG8-CDG	0.005940089	0.2228492713256898
FOLATE MALABSORPTION, HEREDITARY	0.005842762999999999	0.21919797448804235
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.005842762999999999	0.21919797448804235
BARDET-BIEDL SYNDROME 21; BBS21	0.00582633	0.21858147159125163
REVESZ SYNDROME	0.005810534	0.2179888664821597
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005808714	0.21792058708873435
THYROID ECTOPIA	0.005808714	0.21792058708873435
FAMILIAL THYROID DYSHORMONOGENESIS	0.005808714	0.21792058708873435
PERMANENT CONGENITAL HYPOTHYROIDISM	0.005808714	0.21792058708873435
PERIPHERAL HYPOTHYROIDISM	0.005808714	0.21792058708873435
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.005808714	0.21792058708873435
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005808714	0.21792058708873435
PRIMARY CONGENITAL HYPOTHYROIDISM	0.005808714	0.21792058708873435
THYROID HEMIAGENESIS	0.005808714	0.21792058708873435
THYROID HYPOPLASIA	0.005808714	0.21792058708873435
NEURONAL CEROID LIPOFUSCINOSIS	0.005806399	0.21783373720094326
RIFT VALLEY FEVER	0.005804579000000001	0.2177654578075179
ACTH DEFICIENCY, ISOLATED; IAD	0.005804579000000001	0.2177654578075179
CRIGLER-NAJJAR SYNDROME	0.005804579000000001	0.2177654578075179
224250 DYSMYELINATION WITH JAUNDICE	0.005804579000000001	0.2177654578075179
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005804579000000001	0.2177654578075179
TRANSKETOLASE DEFICIENCY	0.005745634	0.21555406833199106
FORSYTHE-WAKELING SYNDROME; FWS	0.005729004	0.21493017475360424
LIG4 SYNDROME	0.005729004	0.21493017475360424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.005729004	0.21493017475360424
CORNELIA DE LANGE SYNDROME 1	0.0057248690000000005	0.2147750454723878
16Q24.3 MICRODELETION SYNDROME	0.005724869	0.21477504547238774
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.005626859	0.21109808758798052
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00562515	0.21103397248723108
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00562515	0.21103397248723108
NEUROENDOCRINE TUMOR OF STOMACH	0.00562515	0.21103397248723108
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00562515	0.21103397248723108
NEUROENDOCRINE TUMOR OF THE COLON	0.00562515	0.21103397248723108
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00562515	0.21103397248723108
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00562515	0.21103397248723108
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00562515	0.21103397248723108
GLYCOGEN STORAGE DISEASE IXA	0.00562515	0.21103397248723108
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.005527824	0.20738267564958368
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.005527824	0.20738267564958368
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.005527824	0.20738267564958368
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.005527824	0.20738267564958368
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.005527824	0.20738267564958368
METHYLMALONIC ACIDURIA, CBLB TYPE	0.005527824	0.20738267564958368
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.005527824	0.20738267564958368
SHWACHMAN-DIAMOND SYNDROME	0.005527824	0.20738267564958368
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.005523689	0.20722754636836724
YOU-HOOVER-FONG SYNDROME; YHFS	0.005519154	0.2070574106270573
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005519154	0.2070574106270573
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.005519154	0.2070574106270573
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005519154	0.2070574106270573
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.005515019	0.20690228134584085
ANGELMAN SYNDROME	0.005515019	0.20690228134584085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.005515019	0.20690228134584085
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0055150189999999995	0.20690228134584085
HOYERAAL-HREIDARSSON SYNDROME	0.0053013439999999995	0.1988860179446499
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005297208999999999	0.1987308886634334
REFSUM DISEASE	0.00526498	0.19752178065755077
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19752178065755077
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19752178065755077
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19752178065755077
46,XX GONADAL DYSGENESIS	0.00526498	0.19752178065755077
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19752178065755077
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00526316	0.19745350126412542
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00526316	0.19745350126412542
ELLIPTOCYTOSIS 1; EL1	0.00526316	0.19745350126412542
EDINBURGH MALFORMATION SYNDROME	0.00526316	0.19745350126412542
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00526316	0.19745350126412542
HYPERBILIRUBINEMIA, ROTOR TYPE	0.00526316	0.19745350126412542
HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	0.00526316	0.19745350126412542
JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	0.00526316	0.19745350126412542
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.00526316	0.19745350126412542
GILBERT SYNDROME	0.00526316	0.19745350126412542
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.00526316	0.19745350126412542
SPECTRIN, BETA, ERYTHROCYTIC	0.00526316	0.19745350126412542
EVANS SYNDROME	0.00526316	0.19745350126412542
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00526316	0.19745350126412542
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00526316	0.19745350126412542
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.00526316	0.19745350126412542
ACETAMINOPHEN METABOLISM	0.00526316	0.19745350126412542
CONGENITAL PANCREATIC CYST	0.00526316	0.19745350126412542
DOMINANT BETA-THALASSEMIA	0.00526316	0.19745350126412542
YELLOW FEVER	0.00526316	0.19745350126412542
SPHEROCYTOSIS, TYPE 2	0.00526316	0.19745350126412542
ROTOR SYNDROME	0.00526316	0.19745350126412542
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00526316	0.19745350126412542
HEREDITARY CHRONIC PANCREATITIS	0.00526316	0.19745350126412542
CRIGLER-NAJJAR SYNDROME, TYPE II	0.00526316	0.19745350126412542
PANCREATOBLASTOMA	0.00526316	0.19745350126412542
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.00526316	0.19745350126412542
RH-NULL, REGULATOR TYPE; RHNR	0.00526316	0.19745350126412542
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.005008543	0.18790125164006538
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.005008543	0.18790125164006538
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.005008543	0.18790125164006538
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.005008543	0.18790125164006538
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.005008543	0.18790125164006538
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.005008543	0.18790125164006538
17Q12 MICRODELETION SYNDROME	0.005008543	0.18790125164006538
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.005008543	0.18790125164006538
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00498227	0.18691558982497475
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00498227	0.18691558982497475
GAUCHER DISEASE, TYPE I	0.00498227	0.18691558982497475
FELTY SYNDROME	0.00498227	0.18691558982497475
DENGUE FEVER	0.00498227	0.18691558982497475
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00498227	0.18691558982497475
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00498227	0.18691558982497475
MUCOLIPIDOSIS TYPE IV	0.0049736	0.18659032480244836
ALLAN-HERNDON-DUDLEY SYNDROME	0.0049736	0.18659032480244836
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0049736	0.18659032480244836
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004874853	0.18288571751531887
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004874853	0.18288571751531887
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.18288571751531887
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004874853	0.18288571751531887
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004874853	0.18288571751531887
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.0046953130000000004	0.17615006790235613
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, X-LINKED 103	0.004583473000000001	0.1719542616602165
ANGELMAN SYNDROME	0.004583473000000001	0.1719542616602165
XQ28 (MECP2) DUPLICATION	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004583473000000001	0.1719542616602165
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.004583473000000001	0.1719542616602165
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004583473000000001	0.1719542616602165
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004583473000000001	0.1719542616602165
IMMUNODEFICIENCY 49; IMD49	0.004583473000000001	0.1719542616602165
LISSENCEPHALY 8; LIS8	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004583473000000001	0.1719542616602165
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004583473000000001	0.1719542616602165
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004583473000000001	0.1719542616602165
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.004583473000000001	0.1719542616602165
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004583473000000001	0.1719542616602165
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004583473000000001	0.1719542616602165
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004583473000000001	0.1719542616602165
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004583473000000001	0.1719542616602165
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004583473000000001	0.1719542616602165
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.004583473000000001	0.1719542616602165
RAYNAUD-CLAES SYNDROME; MRXSRC	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004583473000000001	0.1719542616602165
FOIX-CHAVANY-MARIE SYNDROME	0.004583473000000001	0.1719542616602165
COFFIN-SIRIS SYNDROME 5	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004583473000000001	0.1719542616602165
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004583473000000001	0.1719542616602165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.004583473000000001	0.1719542616602165
PITT-HOPKINS SYNDROME	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004583473000000001	0.1719542616602165
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.004583473000000001	0.1719542616602165
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.004583473000000001	0.1719542616602165
SCHAAF-YANG SYNDROME; SHFYNG	0.004583473000000001	0.1719542616602165
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004583473000000001	0.1719542616602165
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004583473000000001	0.1719542616602165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004583473000000001	0.1719542616602165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.004583473000000001	0.1719542616602165
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.004583473000000001	0.1719542616602165
16P13.2 MICRODELETION SYNDROME	0.004583473000000001	0.1719542616602165
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004583473000000001	0.1719542616602165
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004583473000000001	0.1719542616602165
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004583473000000001	0.1719542616602165
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004583473000000001	0.1719542616602165
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004583473000000001	0.1719542616602165
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004583473000000001	0.1719542616602165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004583473000000001	0.1719542616602165
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004583473000000001	0.1719542616602165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004583473000000001	0.1719542616602165
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004583473000000001	0.1719542616602165
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.004583473000000001	0.1719542616602165
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.004583473000000001	0.1719542616602165
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004583473000000001	0.1719542616602165
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.004583473000000001	0.1719542616602165
PONTINE TEGMENTAL CAP DYSPLASIA	0.004583473000000001	0.1719542616602165
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004583473000000001	0.1719542616602165
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004583473000000001	0.1719542616602165
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004583473000000001	0.1719542616602165
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004583473000000001	0.1719542616602165
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004583473000000001	0.1719542616602165
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004583473000000001	0.1719542616602165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.004583473000000001	0.1719542616602165
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004583473000000001	0.1719542616602165
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.004468833	0.16765341019742236
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004468833	0.16765341019742236
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004468833	0.16765341019742236
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004468833	0.16765341019742236
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.004468833	0.16765341019742236
PELIZAEUS-MERZBACHER DISEASE	0.004468833	0.16765341019742236
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.004468833	0.16765341019742236
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004468833	0.16765341019742236
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.004468833	0.16765341019742236
HSD10 DISEASE	0.004468833	0.16765341019742236
DISTAL MONOSOMY 10Q	0.004468833	0.16765341019742236
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.004468833	0.16765341019742236
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.004468833	0.16765341019742236
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.004468833	0.16765341019742236
15Q11Q13 MICRODUPLICATION SYNDROME	0.004468833	0.16765341019742236
MEDULLOBLASTOMA	0.004467124	0.16758929509667292
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.004365663	0.16378286897780905
HEREDITARY FOLATE MALABSORPTION	0.004365663	0.16378286897780905
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.004365663	0.16378286897780905
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.004365663	0.16378286897780905
STT3B-CDG	0.004365663	0.16378286897780905
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004365663	0.16378286897780905
MIRAGE SYNDROME; MIRAGE	0.004365663	0.16378286897780905
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004365663	0.16378286897780905
JACOBSEN SYNDROME	0.004365663	0.16378286897780905
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.004365663	0.16378286897780905
CUTIS LAXA	0.004333434	0.16257376097192638
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16257376097192638
LARSEN-LIKE SYNDROME	0.004333434	0.16257376097192638
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16257376097192638
EPILEPSY-TELANGIECTASIA	0.004329299	0.16241863169070994
XYLOSIDASE DEFICIENCY	0.004329299	0.16241863169070994
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16241863169070994
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070994
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16241863169070994
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070994
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.004329299	0.16241863169070994
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16241863169070994
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004267653	0.1601059110934018
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004267653	0.1601059110934018
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004267653	0.1601059110934018
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004267653	0.1601059110934018
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004267653	0.1601059110934018
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004267653	0.1601059110934018
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004267653	0.1601059110934018
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004267653	0.1601059110934018
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004267653	0.1601059110934018
RFT1-CDG	0.004267653	0.1601059110934018
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.004267653	0.1601059110934018
TAY-SACHS DISEASE	0.004267653	0.1601059110934018
INFANTILE REFSUM DISEASE	0.004267653	0.1601059110934018
ASPARTYLGLUCOSAMINURIA	0.004149759	0.1556829820777472
JOUBERT SYNDROME 24	0.004042054000000001	0.15164230511682397
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004042054000000001	0.15164230511682397
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.15164230511682397
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682397
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.004042054000000001	0.15164230511682397
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.15164230511682397
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004042054000000001	0.15164230511682397
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.004042054000000001	0.15164230511682397
INFANTILE DYSTONIA-PARKINSONISM	0.004042054000000001	0.15164230511682397
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.15164230511682397
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004042054000000001	0.15164230511682397
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.15164230511682397
HADZISELIMOVIC SYNDROME	0.004042054000000001	0.15164230511682397
HOLMES-GANG SYNDROME	0.004042054000000001	0.15164230511682397
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.004042054000000001	0.15164230511682397
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004042054000000001	0.15164230511682397
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.15164230511682397
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.004042054000000001	0.15164230511682397
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682397
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004042054000000001	0.15164230511682397
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.15164230511682397
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682397
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.004042054000000001	0.15164230511682397
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004037919000000001	0.15148717583560756
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004037919000000001	0.15148717583560756
HALL-RIGGS SYNDROME	0.004037919000000001	0.15148717583560756
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004037919000000001	0.15148717583560756
PITT-HOPKINS SYNDROME	0.004037919000000001	0.15148717583560756
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004037919000000001	0.15148717583560756
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004037919000000001	0.15148717583560756
ADENYLOSUCCINATE LYASE DEFICIENCY	0.004037919000000001	0.15148717583560756
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.004037919000000001	0.15148717583560756
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004037919000000001	0.15148717583560756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.004037919000000001	0.15148717583560756
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.004037919000000001	0.15148717583560756
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.004037919000000001	0.15148717583560756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.004037919000000001	0.15148717583560756
TEMPLE-BARAITSER SYNDROME	0.004037919000000001	0.15148717583560756
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004037919000000001	0.15148717583560756
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004037919000000001	0.15148717583560756
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004037919000000001	0.15148717583560756
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.004037919000000001	0.15148717583560756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.004037919000000001	0.15148717583560756
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.004037919000000001	0.15148717583560756
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.004037919000000001	0.15148717583560756
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.004037919000000001	0.15148717583560756
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.004037919000000001	0.15148717583560756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.004037919000000001	0.15148717583560756
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.004037919000000001	0.15148717583560756
CHILDHOOD DISINTEGRATIVE DISORDER	0.004037919000000001	0.15148717583560756
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004037919000000001	0.15148717583560756
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004037919000000001	0.15148717583560756
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.004037919000000001	0.15148717583560756
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003927414	0.14734145365402987
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.003927414	0.14734145365402987
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003927414	0.14734145365402987
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.003927414	0.14734145365402987
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.003927414	0.14734145365402987
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.003923279	0.14718632437281343
2Q23.1 MICRODELETION SYNDROME	0.003923279	0.14718632437281343
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.003923279	0.14718632437281343
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.003923279	0.14718632437281343
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00392157	0.147122209272064
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.147122209272064
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00392157	0.147122209272064
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00392157	0.147122209272064
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.00392157	0.147122209272064
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.147122209272064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.147122209272064
PRIMARY HYPEROXALURIA	0.00392157	0.147122209272064
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00392157	0.147122209272064
BECKER MUSCULAR DYSTROPHY	0.00392157	0.147122209272064
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00392157	0.147122209272064
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.147122209272064
DPM3-CDG	0.00392157	0.147122209272064
COMMON VARIABLE IMMUNODEFICIENCY	0.00392157	0.147122209272064
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.147122209272064
XFE PROGEROID SYNDROME; XFEPS	0.00392157	0.147122209272064
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003824244	0.1434709124344166
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.003824244	0.1434709124344166
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.003824244	0.1434709124344166
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.003824244	0.1434709124344166
ROBERTS SYNDROME	0.003824244	0.1434709124344166
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.003824244	0.1434709124344166
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.003824244	0.1434709124344166
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003820109	0.14331578315320015
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.003820109	0.14331578315320015
VIRAL HEMORRHAGIC FEVER	0.003820109	0.14331578315320015
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.003820109	0.14331578315320015
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.003820109	0.14331578315320015
EBOLA HEMORRHAGIC FEVER	0.003820109	0.14331578315320015
SMITH-KINGSMORE SYNDROME; SKS	0.003820109	0.14331578315320015
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.003820109	0.14331578315320015
DUBOWITZ SYNDROME	0.003820109	0.14331578315320015
BERNARD-SOULIER SYNDROME	0.003820109	0.14331578315320015
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003820109	0.14331578315320015
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731745
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731745
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731745
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731745
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731745
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731745
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731745
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731745
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731745
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731745
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731745
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731745
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731745
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731745
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731745
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731745
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731745
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731745
HOOFT DISEASE	0.00378788	0.14210667514731745
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.14210667514731745
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731745
NEPHROSIALIDOSIS	0.00378788	0.14210667514731745
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731745
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731745
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731745
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.14210667514731745
DERMATITIS, ATOPIC	0.00378788	0.14210667514731745
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731745
AREDYLD	0.00378788	0.14210667514731745
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.14210667514731745
ACETYLATION, SLOW	0.00378788	0.14210667514731745
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.14210667514731745
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.14210667514731745
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731745
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.14210667514731745
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731745
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.14210667514731745
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731745
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.14210667514731745
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731745
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731745
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731745
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731745
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.14210667514731745
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731745
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731745
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731745
BARTTER SYNDROME	0.00378788	0.14210667514731745
HYPOASCORBEMIA	0.00378788	0.14210667514731745
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731745
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731745
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731745
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731745
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731745
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731745
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731745
ONCOCYTOMA	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731745
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731745
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731745
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.14210667514731745
GLOMUVENOUS MALFORMATIONS	0.00378788	0.14210667514731745
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731745
PENDRED SYNDROME	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731745
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731745
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.14210667514731745
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731745
ETHANOLAMINOSIS	0.00378788	0.14210667514731745
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.14210667514731745
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731745
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731745
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731745
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731745
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731745
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731745
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.14210667514731745
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731745
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.14210667514731745
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731745
XM SYSTEM	0.00378788	0.14210667514731745
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731745
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731745
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731745
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731745
CARBOXYLESTERASE 1	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731745
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731745
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731745
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731745
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731745
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731745
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731745
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731745
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731745
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731745
BEETURIA	0.00378788	0.14210667514731745
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731745
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731745
OSTEOMESOPYKNOSIS	0.00378788	0.14210667514731745
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.14210667514731745
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731745
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731745
COUMARIN RESISTANCE	0.00378788	0.14210667514731745
ICHTHYOSIS, X-LINKED	0.00378788	0.14210667514731745
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731745
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731745
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731745
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731745
GONADOBLASTOMA	0.00378788	0.14210667514731745
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731745
GLUTATHIONURIA	0.00378788	0.14210667514731745
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731745
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731745
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731745
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.14210667514731745
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731745
PITUITARY DWARFISM IV	0.00378788	0.14210667514731745
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.14210667514731745
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731745
LARON SYNDROME	0.00378788	0.14210667514731745
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731745
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.14210667514731745
SPINAL ARACHNOIDITIS	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731745
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.14210667514731745
SCHIZOPHRENIA 4	0.00378788	0.14210667514731745
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731745
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731745
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731745
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731745
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731745
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731745
TRISOMY 18-LIKE SYNDROME	0.00378788	0.14210667514731745
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731745
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731745
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731745
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731745
PARAOXONASE 1	0.00378788	0.14210667514731745
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731745
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731745
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.14210667514731745
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731745
OVARIAN CANCER	0.00378788	0.14210667514731745
PACMAN DYSPLASIA	0.00378788	0.14210667514731745
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731745
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731745
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731745
PERRY SYNDROME	0.00378788	0.14210667514731745
PYGMY	0.00378788	0.14210667514731745
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.14210667514731745
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731745
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.14210667514731745
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731745
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.14210667514731745
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731745
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.14210667514731745
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.003726234	0.13979395455000934
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.003722099	0.1396388252687929
SANDHOFF DISEASE	0.003722099	0.1396388252687929
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003722099	0.1396388252687929
MUCOPOLYSACCHARIDOSIS TYPE 3	0.003722099	0.1396388252687929
COCKAYNE SYNDROME A; CSA	0.003722099	0.1396388252687929
RETT SYNDROME	0.0037220989999999995	0.13963882526879287
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.13117521929221507
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.13117521929221507
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.13117521929221507
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.13117521929221507
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0034965000000000005	0.13117521929221507
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0034965000000000005	0.13117521929221507
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.13117521929221507
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0034965000000000005	0.13117521929221507
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.13117521929221507
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.13117521929221507
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.13117521929221507
GABRIELE-DE VRIES SYNDROME	0.0034965000000000005	0.13117521929221507
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.13117521929221507
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.13117521929221507
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.13117521929221507
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.13117521929221507
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0033818599999999996	0.12687436782942094
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0033818599999999996	0.12687436782942094
FANCONI ANEMIA	0.00327869	0.12300382660980766
ISOLATED AGAMMAGLOBULINEMIA	0.00327869	0.12300382660980766
SLC35A1-CDG	0.00327869	0.12300382660980766
MALARIA	0.00327869	0.12300382660980766
WISKOTT-ALDRICH SYNDROME	0.00327869	0.12300382660980766
HERMANSKY-PUDLAK SYNDROME 9	0.00327869	0.12300382660980766
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00327869	0.12300382660980766
JACOBSEN SYNDROME	0.00327869	0.12300382660980766
IVIC SYNDROME	0.00327869	0.12300382660980766
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00327869	0.12300382660980766
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00327869	0.12300382660980766
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00327869	0.12300382660980766
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00327869	0.12300382660980766
REFRACTORY ANEMIA	0.00327869	0.12300382660980766
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00327869	0.12300382660980766
EOSINOPHILIA, FAMILIAL	0.00327869	0.12300382660980766
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00327869	0.12300382660980766
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00327869	0.12300382660980766
GOOD SYNDROME	0.00327869	0.12300382660980766
DIAMOND-BLACKFAN ANEMIA 1	0.00327869	0.12300382660980766
CERNUNNOS-XLF DEFICIENCY	0.00327869	0.12300382660980766
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00327869	0.12300382660980766
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00327869	0.12300382660980766
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00327869	0.12300382660980766
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00327869	0.12300382660980766
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00327869	0.12300382660980766
SENGERS SYNDROME	0.00327869	0.12300382660980766
BEEMER LETHAL MALFORMATION SYNDROME	0.00327869	0.12300382660980766
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.00327869	0.12300382660980766
AREGENERATIVE ANEMIA	0.00327869	0.12300382660980766
FIBULAR HEMIMELIA	0.00327869	0.12300382660980766
TUFTED ANGIOMA	0.00327869	0.12300382660980766
WT LIMB-BLOOD SYNDROME	0.00327869	0.12300382660980766
BEEMER-ERTBRUGGEN SYNDROME	0.00327869	0.12300382660980766
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00327869	0.12300382660980766
THROMBOCYTOPENIA, CYCLIC	0.00327869	0.12300382660980766
THROMBOCYTOPENIA 2	0.00327869	0.12300382660980766
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00327869	0.12300382660980766
STORMORKEN SYNDROME; STRMK	0.00327869	0.12300382660980766
PLATELET SIGNAL PROCESSING DEFECT	0.00327869	0.12300382660980766
PLATELET DISORDER, UNDEFINED	0.00327869	0.12300382660980766
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00327869	0.12300382660980766
IVIC SYNDROME	0.00327869	0.12300382660980766
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00327869	0.12300382660980766
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00327869	0.12300382660980766
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00327869	0.12300382660980766
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12300382660980766
IMMUNE THROMBOCYTOPENIC PURPURA	0.00327869	0.12300382660980766
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00327869	0.12300382660980766
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.00327869	0.12300382660980766
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00327869	0.12300382660980766
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00327869	0.12300382660980766
OSTEOPETROSIS AND RELATED DISORDERS	0.00327869	0.12300382660980766
THROMBOCYTOPENIA 5; THC5	0.00327869	0.12300382660980766
ACQUIRED PURPURA FULMINANS	0.00327869	0.12300382660980766
IMMUNODEFICIENCY 52; IMD52	0.00327869	0.12300382660980766
MONOSOMY 7 OF BONE MARROW	0.00327869	0.12300382660980766
SEBASTIAN SYNDROME	0.00327869	0.12300382660980766
TRANSCOBALAMIN DEFICIENCY	0.00327869	0.12300382660980766
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00327869	0.12300382660980766
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00327869	0.12300382660980766
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00327869	0.12300382660980766
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00327869	0.12300382660980766
CHRONIC MYELOID LEUKEMIA	0.00327869	0.12300382660980766
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00327869	0.12300382660980766
CYCLIC NEUTROPENIA	0.00327869	0.12300382660980766
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00327869	0.12300382660980766
THROMBOCYTOPENIA 3	0.00327869	0.12300382660980766
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00327869	0.12300382660980766
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00327869	0.12300382660980766
GRAY PLATELET SYNDROME	0.00327869	0.12300382660980766
OSTEOGENESIS IMPERFECTA	0.00327869	0.12300382660980766
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00327869	0.12300382660980766
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00327869	0.12300382660980766
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.00327869	0.12300382660980766
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.00327869	0.12300382660980766
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00327869	0.12300382660980766
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.00327869	0.12300382660980766
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00327869	0.12300382660980766
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.00327869	0.12300382660980766
IDIOPATHIC APLASTIC ANEMIA	0.00327869	0.12300382660980766
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00327869	0.12300382660980766
ACUTE PROMYELOCYTIC LEUKEMIA	0.00327869	0.12300382660980766
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12300382660980766
THROMBOCYTOPENIA 6	0.00327869	0.12300382660980766
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00318068	0.11932686872540041
HODGKIN LYMPHOMA	0.00318068	0.11932686872540041
CAMURATI-ENGELMANN DISEASE	0.00318068	0.11932686872540041
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00318068	0.11932686872540041
CLASSIC HODGKIN LYMPHOMA	0.00318068	0.11932686872540041
TYPHOID	0.00318068	0.11932686872540041
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00318068	0.11932686872540041
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.002991733	0.11223830468718901
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002991733	0.11223830468718901
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002991733	0.11223830468718901
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002991733	0.11223830468718901
CHROMOSOME 5Q12 DELETION SYNDROME	0.002991733	0.11223830468718901
CK SYNDROME	0.002991733	0.11223830468718901
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002991733	0.11223830468718901
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.002991733	0.11223830468718901
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002991733	0.11223830468718901
WIEACKER-WOLFF SYNDROME	0.002991733	0.11223830468718901
AL KAISSI SYNDROME; ALKAS	0.002991733	0.11223830468718901
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002991733	0.11223830468718901
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002991733	0.11223830468718901
GENITOPATELLAR SYNDROME	0.002991733	0.11223830468718901
11Q22.2Q22.3 MICRODELETION SYNDROME	0.002991733	0.11223830468718901
15Q14 MICRODELETION SYNDROME	0.002991733	0.11223830468718901
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002991733	0.11223830468718901
SHASHI-PENA SYNDROME; SHAPNS	0.002991733	0.11223830468718901
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.002991733	0.11223830468718901
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002991733	0.11223830468718901
48,XXXY SYNDROME	0.002991733	0.11223830468718901
LANDAU-KLEFFNER SYNDROME	0.002991733	0.11223830468718901
KLEEFSTRA SYNDROME	0.002991733	0.11223830468718901
MENTAL RETARDATION, X-LINKED 90	0.002991733	0.11223830468718901
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002991733	0.11223830468718901
PRADER-WILLI SYNDROME; PWS	0.002991733	0.11223830468718901
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.002991733	0.11223830468718901
FG SYNDROME TYPE 1	0.002991733	0.11223830468718901
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002991733	0.11223830468718901
EMANUEL SYNDROME	0.002991733	0.11223830468718901
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002991733	0.11223830468718901
GLASS SYNDROME	0.002991733	0.11223830468718901
17Q11.2 MICRODUPLICATION SYNDROME	0.002991733	0.11223830468718901
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.002991733	0.11223830468718901
KLEEFSTRA SYNDROME 2; KLEFS2	0.002991733	0.11223830468718901
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002991733	0.11223830468718901
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.002991733	0.11223830468718901
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002991733	0.11223830468718901
SMITH-MAGENIS SYNDROME	0.002991733	0.11223830468718901
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002991733	0.11223830468718901
JOUBERT SYNDROME 30; JBTS30	0.002991733	0.11223830468718901
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002991733	0.11223830468718901
MEHMO SYNDROME; MEHMO	0.002991733	0.11223830468718901
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002991733	0.11223830468718901
SHUKLA-VERNON SYNDROME; SHUVER	0.002991733	0.11223830468718901
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002991733	0.11223830468718901
WIEDEMANN-STEINER SYNDROME; WDSTS	0.002991733	0.11223830468718901
WEAVER SYNDROME	0.002991733	0.11223830468718901
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002991733	0.11223830468718901
MENTAL RETARDATION, X-LINKED 9	0.002991733	0.11223830468718901
ADENYLOSUCCINASE DEFICIENCY	0.002991733	0.11223830468718901
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002991733	0.11223830468718901
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002991733	0.11223830468718901
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.002991733	0.11223830468718901
LUSCAN-LUMISH SYNDROME; LLS	0.002991733	0.11223830468718901
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.002991733	0.11223830468718901
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.002991733	0.11223830468718901
6Q TERMINAL DELETION SYNDROME	0.002991733	0.11223830468718901
DISTAL MONOSOMY 15Q	0.002991733	0.11223830468718901
DESANTO-SHINAWI SYNDROME	0.002991733	0.11223830468718901
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.002991733	0.11223830468718901
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002991733	0.11223830468718901
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002991733	0.11223830468718901
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002991733	0.11223830468718901
WITTEVEEN-KOLK SYNDROME	0.002991733	0.11223830468718901
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002991733	0.11223830468718901
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002991733	0.11223830468718901
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002991733	0.11223830468718901
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002991733	0.11223830468718901
11P15.4 MICRODUPLICATION SYNDROME	0.002991733	0.11223830468718901
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002991733	0.11223830468718901
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002991733	0.11223830468718901
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002991733	0.11223830468718901
XQ25 DUPLICATION SYNDROME	0.002991733	0.11223830468718901
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002991733	0.11223830468718901
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002991733	0.11223830468718901
COFFIN-SIRIS SYNDROME 2; CSS2	0.002991733	0.11223830468718901
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002991733	0.11223830468718901
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002991733	0.11223830468718901
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002991733	0.11223830468718901
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002991733	0.11223830468718901
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0027905530000000003	0.10469080558316848
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0027905530000000003	0.10469080558316848
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0027905530000000003	0.10469080558316848
KAGAMI-OGATA SYNDROME	0.0027905530000000003	0.10469080558316848
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0027905530000000003	0.10469080558316848
C SYNDROME	0.0027905530000000003	0.10469080558316848
PYRUVATE CARBOXYLASE DEFICIENCY	0.0027905530000000003	0.10469080558316848
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0027905530000000003	0.10469080558316848
MUCOPOLYSACCHARIDOSIS TYPE 2	0.0027905530000000003	0.10469080558316848
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027905530000000003	0.10469080558316848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0027905530000000003	0.10469080558316848
MULTIPLE SULFATASE DEFICIENCY	0.0027905530000000003	0.10469080558316848
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.002564073	0.09619414787823473
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002564073	0.09619414787823473
GRISCELLI SYNDROME TYPE 1	0.002564073	0.09619414787823473
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002564073	0.09619414787823473
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002564073	0.09619414787823473
PYRUVATE DEHYDROGENASE DEFICIENCY	0.002564073	0.09619414787823473
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002564073	0.09619414787823473
OROFACIODIGITAL SYNDROME TYPE 6	0.002564073	0.09619414787823473
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002564073	0.09619414787823473
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002564073	0.09619414787823473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002564073	0.09619414787823473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002564073	0.09619414787823473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.002564073	0.09619414787823473
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002564073	0.09619414787823473
MYHRE SYNDROME	0.002564073	0.09619414787823473
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.002564073	0.09619414787823473
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002564073	0.09619414787823473
SULFOCYSTEINURIA	0.002564073	0.09619414787823473
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.002564073	0.09619414787823473
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002564073	0.09619414787823473
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002564073	0.09619414787823473
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.002564073	0.09619414787823473
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002564073	0.09619414787823473
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002564073	0.09619414787823473
HARTNUP DISEASE	0.002564073	0.09619414787823473
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002564073	0.09619414787823473
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.002564073	0.09619414787823473
MAPLE SYRUP URINE DISEASE	0.002564073	0.09619414787823473
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002564073	0.09619414787823473
MEVALONIC ACIDURIA	0.002564073	0.09619414787823473
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002564073	0.09619414787823473
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002564073	0.09619414787823473
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002564073	0.09619414787823473
CENTRAL BILATERAL MACROGYRIA	0.002564073	0.09619414787823473
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002564073	0.09619414787823473
CEDNIK SYNDROME	0.002564073	0.09619414787823473
ELEJALDE DISEASE	0.002564073	0.09619414787823473
JOUBERT SYNDROME	0.002564073	0.09619414787823473
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002564073	0.09619414787823473
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002564073	0.09619414787823473
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.002564073	0.09619414787823473
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.002564073	0.09619414787823473
EAST SYNDROME	0.002564073	0.09619414787823473
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002564073	0.09619414787823473
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002564073	0.09619414787823473
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002564073	0.09619414787823473
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002564073	0.09619414787823473
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002564073	0.09619414787823473
48,XXYY SYNDROME	0.002564073	0.09619414787823473
JOUBERT SYNDROME WITH RENAL DEFECT	0.002564073	0.09619414787823473
COWDEN SYNDROME	0.002564073	0.09619414787823473
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.09192634814379654
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.002450314	0.09192634814379654
DE BARSY SYNDROME	0.002450314	0.09192634814379654
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.002450314	0.09192634814379654
6Q16 MICRODELETION SYNDROME	0.002450314	0.09192634814379654
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.002450314	0.09192634814379654
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002450314	0.09192634814379654
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.002450314	0.09192634814379654
BARATELA-SCOTT SYNDROME	0.002450314	0.09192634814379654
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	0.09192634814379654
SAUL-WILSON SYNDROME; SWILS	0.002450314	0.09192634814379654
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.002450314	0.09192634814379654
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.002450314	0.09192634814379654
OKAMOTO SYNDROME	0.002450314	0.09192634814379654
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.002450314	0.09192634814379654
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	0.09192634814379654
3Q29 MICRODELETION SYNDROME	0.002450314	0.09192634814379654
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.002450314	0.09192634814379654
8P23.1 DUPLICATION SYNDROME	0.002450314	0.09192634814379654
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.002450314	0.09192634814379654
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.002450314	0.09192634814379654
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.002450314	0.09192634814379654
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.002450314	0.09192634814379654
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.002450314	0.09192634814379654
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.002450314	0.09192634814379654
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.002450314	0.09192634814379654
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002450314	0.09192634814379654
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.002450314	0.09192634814379654
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.09192634814379654
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002450314	0.09192634814379654
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.002450314	0.09192634814379654
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002450314	0.09192634814379654
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.002450314	0.09192634814379654
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	0.09192634814379654
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.002450314	0.09192634814379654
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002450314	0.09192634814379654
48,XYYY SYNDROME	0.002450314	0.09192634814379654
1P21.3 MICRODELETION SYNDROME	0.002450314	0.09192634814379654
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.09192634814379654
EPIDERMAL NEVUS SYNDROME	0.002450314	0.09192634814379654
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.09192634814379654
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.002450314	0.09192634814379654
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.002450314	0.09192634814379654
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002450314	0.09192634814379654
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002450314	0.09192634814379654
DISTAL MONOSOMY 6P	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.002450314	0.09192634814379654
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	0.09192634814379654
COFFIN-SIRIS SYNDROME 6; CSS6	0.002450314	0.09192634814379654
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.002450314	0.09192634814379654
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.002450314	0.09192634814379654
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.002450314	0.09192634814379654
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.002450314	0.09192634814379654
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.002450314	0.09192634814379654
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	0.09192634814379654
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.002450314	0.09192634814379654
SAY-BARBER-MILLER SYNDROME	0.002450314	0.09192634814379654
SPINOCEREBELLAR ATAXIA TYPE 29	0.002450314	0.09192634814379654
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.002450314	0.09192634814379654
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.002450314	0.09192634814379654
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.002450314	0.09192634814379654
2P15P16.1 MICRODELETION SYNDROME	0.002450314	0.09192634814379654
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002450314	0.09192634814379654
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002450314	0.09192634814379654
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002450314	0.09192634814379654
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.002450314	0.09192634814379654
16P11.2P12.2 MICRODELETION SYNDROME	0.002450314	0.09192634814379654
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.002450314	0.09192634814379654
LAMB-SHAFFER SYNDROME	0.002450314	0.09192634814379654
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.002450314	0.09192634814379654
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.002450314	0.09192634814379654
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.002450314	0.09192634814379654
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002450314	0.09192634814379654
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.09192634814379654
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002450314	0.09192634814379654
TONNE-KALSCHEUER SYNDROME; TOKAS	0.002450314	0.09192634814379654
COFFIN-SIRIS SYNDROME 7; CSS7	0.002450314	0.09192634814379654
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.002450314	0.09192634814379654
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.002450314	0.09192634814379654
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	0.09192634814379654
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.002450314	0.09192634814379654
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.002450314	0.09192634814379654
2Q32Q33 MICRODELETION SYNDROME	0.002450314	0.09192634814379654
CHROMOSOME 9P DELETION SYNDROME	0.002450314	0.09192634814379654
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	0.09192634814379654
FAMILIAL MULTIPLE LIPOMATOSIS	0.0024461789999999997	0.09177121886258008
17Q24.2 MICRODELETION SYNDROME	0.0024461789999999997	0.09177121886258008
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0024461789999999997	0.09177121886258008
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.0024461789999999997	0.09177121886258008
4Q21 MICRODELETION SYNDROME	0.0024461789999999997	0.09177121886258008
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0024461789999999997	0.09177121886258008
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0024461789999999997	0.09177121886258008
17Q12 MICRODUPLICATION SYNDROME	0.0024461789999999997	0.09177121886258008
9Q21.13 MICRODELETION SYNDROME	0.0024461789999999997	0.09177121886258008
20Q13.33 MICRODELETION SYNDROME	0.0024461789999999997	0.09177121886258008
20P13 MICRODELETION SYNDROME	0.0024461789999999997	0.09177121886258008
47,XYY SYNDROME	0.0024461789999999997	0.09177121886258008
WIEDEMANN-STEINER SYNDROME	0.0024461789999999997	0.09177121886258008
5Q14.3 MICRODELETION SYNDROME	0.0024461789999999997	0.09177121886258008
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.0024461789999999997	0.09177121886258008
PARTINGTON SYNDROME	0.0024461789999999997	0.09177121886258008
ADNP SYNDROME	0.0024461789999999997	0.09177121886258008
SMITH-FINEMAN-MYERS SYNDROME	0.0024461789999999997	0.09177121886258008
7Q11.23 MICRODUPLICATION SYNDROME	0.0024461789999999997	0.09177121886258008
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0024461789999999997	0.09177121886258008
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.0024461789999999997	0.09177121886258008
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0024461789999999997	0.09177121886258008
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0024461789999999997	0.09177121886258008
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0024461789999999997	0.09177121886258008
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0024461789999999997	0.09177121886258008
HUNTINGTON DISEASE-LIKE 1	0.0024461789999999997	0.09177121886258008
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.0024461789999999997	0.09177121886258008
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.0024461789999999997	0.09177121886258008
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.0024461789999999997	0.09177121886258008
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0024461789999999997	0.09177121886258008
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.0024461789999999997	0.09177121886258008
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0024461789999999997	0.09177121886258008
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0024461789999999997	0.09177121886258008
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.0024461789999999997	0.09177121886258008
AUTISM	0.0024461789999999997	0.09177121886258008
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0024461789999999997	0.09177121886258008
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0024461789999999997	0.09177121886258008
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0024461789999999997	0.09177121886258008
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0024461789999999997	0.09177121886258008
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0024461789999999997	0.09177121886258008
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0024461789999999997	0.09177121886258008
TENORIO SYNDROME; TNORS	0.0024461789999999997	0.09177121886258008
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0024461789999999997	0.09177121886258008
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0024461789999999997	0.09177121886258008
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.0024461789999999997	0.09177121886258008
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0024461789999999997	0.09177121886258008
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0024461789999999997	0.09177121886258008
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.0024461789999999997	0.09177121886258008
KLEEFSTRA SYNDROME	0.0024461789999999997	0.09177121886258008
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0024461789999999997	0.09177121886258008
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0024461789999999997	0.09177121886258008
COFFIN-SIRIS SYNDROME 8; CSS8	0.0024461789999999997	0.09177121886258008
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.0024461789999999997	0.09177121886258008
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.0024461789999999997	0.09177121886258008
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.002249134	0.084378849039776
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.002249134	0.084378849039776
LIG4 SYNDROME	0.002249134	0.084378849039776
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.002249134	0.084378849039776
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002249134	0.084378849039776
PEROXISOME BIOGENESIS DISORDER 3B	0.002249134	0.084378849039776
MACROCEPHALY/AUTISM SYNDROME	0.002249134	0.084378849039776
HURLER SYNDROME	0.002249134	0.084378849039776
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.002249134	0.084378849039776
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.002249134	0.084378849039776
ROIFMAN SYNDROME; RFMN	0.002249134	0.084378849039776
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002249134	0.084378849039776
WOLMAN DISEASE	0.002249134	0.084378849039776
ALPHA-MANNOSIDOSIS	0.002249134	0.084378849039776
OCULOSKELETODENTAL SYNDROME; OCSKD	0.002249134	0.084378849039776
GLUTARIC ACIDEMIA I; GA1	0.002244999	0.08422371975855956
MUCOPOLYSACCHARIDOSIS, TYPE II	0.002244999	0.08422371975855956
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.002244999	0.08422371975855956
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002244999	0.08422371975855956
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.002244999	0.08422371975855956
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.002244999	0.08422371975855956
GAUCHER DISEASE, TYPE IIIC	0.002244999	0.08422371975855956
ZIMMERMANN-LABAND SYNDROME 1	0.002244999	0.08422371975855956
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002244999	0.08422371975855956
ZIMMERMANN-LABAND SYNDROME	0.002244999	0.08422371975855956
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002244999	0.08422371975855956
JOUBERT SYNDROME 28	0.0020226539999999996	0.07588219133484224
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0020226539999999996	0.07588219133484224
WAARDENBURG-SHAH SYNDROME	0.0020226539999999996	0.07588219133484224
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 21	0.0020226539999999996	0.07588219133484224
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07588219133484224
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07588219133484224
MARINESCO-SJÖGREN SYNDROME	0.0020226539999999996	0.07588219133484224
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0020226539999999996	0.07588219133484224
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07588219133484224
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07588219133484224
BAKER-GORDON SYNDROME; BAGOS	0.0020226539999999996	0.07588219133484224
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0020226539999999996	0.07588219133484224
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07588219133484224
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07588219133484224
BRAIN-LUNG-THYROID SYNDROME	0.0020226539999999996	0.07588219133484224
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0020226539999999996	0.07588219133484224
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0020226539999999996	0.07588219133484224
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07588219133484224
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0020226539999999996	0.07588219133484224
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0020226539999999996	0.07588219133484224
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07588219133484224
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0020226539999999996	0.07588219133484224
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07588219133484224
MARINESCO-SJOGREN SYNDROME; MSS	0.0020226539999999996	0.07588219133484224
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07588219133484224
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07588219133484224
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07588219133484224
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 27	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 25	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07588219133484224
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07588219133484224
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0020226539999999996	0.07588219133484224
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 15	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 14	0.0020226539999999996	0.07588219133484224
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0020226539999999996	0.07588219133484224
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0020226539999999996	0.07588219133484224
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0020226539999999996	0.07588219133484224
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07588219133484224
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07588219133484224
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07588219133484224
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07588219133484224
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 8	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 7	0.0020226539999999996	0.07588219133484224
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07588219133484224
ALEXANDER DISEASE	0.002018519	0.0757270620536258
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002018519	0.0757270620536258
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.0757270620536258
KALLMANN SYNDROME	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.0757270620536258
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.0757270620536258
CAMOS SYNDROME	0.002018519	0.0757270620536258
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.002018519	0.0757270620536258
TYROSINEMIA TYPE 2	0.002018519	0.0757270620536258
TRIPLE A SYNDROME	0.002018519	0.0757270620536258
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002018519	0.0757270620536258
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.0757270620536258
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.0757270620536258
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.0757270620536258
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.0757270620536258
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.0757270620536258
CYCLIC VOMITING SYNDROME	0.002018519	0.0757270620536258
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.002018519	0.0757270620536258
OCULODENTODIGITAL DYSPLASIA	0.002018519	0.0757270620536258
LHERMITTE-DUCLOS DISEASE	0.002018519	0.0757270620536258
FLYNN-AIRD SYNDROME	0.002018519	0.0757270620536258
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.0757270620536258
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.0757270620536258
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.0757270620536258
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.0757270620536258
ALEXANDER DISEASE	0.002018519	0.0757270620536258
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.0757270620536258
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.0757270620536258
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002018519	0.0757270620536258
LISSENCEPHALY 3; LIS3	0.002018519	0.0757270620536258
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.0757270620536258
EPISODIC ATAXIA TYPE 6	0.002018519	0.0757270620536258
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.0757270620536258
DYSEQUILIBRIUM SYNDROME	0.002018519	0.0757270620536258
BANGSTAD SYNDROME	0.002018519	0.0757270620536258
WOLFRAM SYNDROME	0.002018519	0.0757270620536258
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.002018519	0.0757270620536258
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002018519	0.0757270620536258
GM1 GANGLIOSIDOSIS	0.002018519	0.0757270620536258
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.002018519	0.0757270620536258
KUFOR-RAKEB SYNDROME	0.002018519	0.0757270620536258
COCKAYNE SYNDROME	0.002018519	0.0757270620536258
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.0757270620536258
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.0757270620536258
ISOLATED CEREBELLAR AGENESIS	0.002018519	0.0757270620536258
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.0757270620536258
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002018519	0.0757270620536258
FAMILIAL DYSAUTONOMIA	0.002018519	0.0757270620536258
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.0757270620536258
HEREDITARY HYPEREKPLEXIA	0.002018519	0.0757270620536258
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.0757270620536258
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.0757270620536258
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.0757270620536258
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.0757270620536258
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.0757270620536258
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.0757270620536258
LEIGH SYNDROME	0.002018519	0.0757270620536258
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.002018519	0.0757270620536258
XERODERMA PIGMENTOSUM	0.002018519	0.0757270620536258
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.0757270620536258
GITELMAN SYNDROME	0.002018519	0.0757270620536258
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.0757270620536258
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.0757270620536258
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.0757270620536258
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002018519	0.0757270620536258
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.0757270620536258
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.0757270620536258
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.0757270620536258
FLYNN-AIRD SYNDROME	0.002018519	0.0757270620536258
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002018519	0.0757270620536258
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.0757270620536258
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.0757270620536258
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.0757270620536258
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.0757270620536258
DIAMINOPENTANURIA	0.002018519	0.0757270620536258
CITRULLINEMIA TYPE I	0.002018519	0.0757270620536258
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.0757270620536258
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.0757270620536258
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.0757270620536258
SIALIDOSIS TYPE 1	0.002018519	0.0757270620536258
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.07145926231918763
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.07145926231918763
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	0.07145926231918763
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.07145926231918763
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	0.07145926231918763
NAGER SYNDROME	0.00190476	0.07145926231918763
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00190476	0.07145926231918763
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00190476	0.07145926231918763
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00190476	0.07145926231918763
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.07145926231918763
PRIMARY CILIARY DYSKINESIA	0.00190476	0.07145926231918763
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	0.07145926231918763
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.07145926231918763
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.07145926231918763
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.07145926231918763
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.07145926231918763
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.07145926231918763
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.07145926231918763
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00190476	0.07145926231918763
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00190476	0.07145926231918763
CRANIOSYNOSTOSIS 7	0.00190476	0.07145926231918763
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00190476	0.07145926231918763
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.07145926231918763
MOEBIUS SYNDROME; MBS	0.00190476	0.07145926231918763
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	0.07145926231918763
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.07145926231918763
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00190476	0.07145926231918763
CHITAYAT SYNDROME	0.00190476	0.07145926231918763
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00190476	0.07145926231918763
TEMPLE SYNDROME	0.00190476	0.07145926231918763
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00190476	0.07145926231918763
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.07145926231918763
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00190476	0.07145926231918763
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.07145926231918763
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00190476	0.07145926231918763
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.07145926231918763
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.07145926231918763
MASA SYNDROME	0.00190476	0.07145926231918763
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.07145926231918763
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00190476	0.07145926231918763
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.07145926231918763
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00190476	0.07145926231918763
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	0.07145926231918763
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.07145926231918763
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	0.07145926231918763
CLEFT LIP/PALATE	0.00190476	0.07145926231918763
TEMPLE SYNDROME	0.00190476	0.07145926231918763
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.07145926231918763
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	0.07145926231918763
EPISODIC ATAXIA TYPE 1	0.00190476	0.07145926231918763
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00190476	0.07145926231918763
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.07145926231918763
DUBOWITZ SYNDROME	0.00190476	0.07145926231918763
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.07145926231918763
3Q27.3 MICRODELETION SYNDROME	0.00190476	0.07145926231918763
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.07145926231918763
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.07145926231918763
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00190476	0.07145926231918763
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	0.07145926231918763
FG SYNDROME 2; FGS2	0.00190476	0.07145926231918763
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.07145926231918763
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00190476	0.07145926231918763
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	0.07145926231918763
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.07145926231918763
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.07145926231918763
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.07145926231918763
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	0.07145926231918763
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.07145926231918763
SOTOS SYNDROME 2	0.00190476	0.07145926231918763
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	0.07145926231918763
MILD CANAVAN DISEASE	0.00190476	0.07145926231918763
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.07145926231918763
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.07145926231918763
MICROTRIPLICATION 11Q24.1	0.00190476	0.07145926231918763
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	0.07145926231918763
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.07145926231918763
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	0.07145926231918763
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.07145926231918763
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.07145926231918763
DYSTONIA 16; DYT16	0.00190476	0.07145926231918763
MICROTIA	0.00190476	0.07145926231918763
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.07145926231918763
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.07145926231918763
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.07145926231918763
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.07145926231918763
MACHADO-JOSEPH DISEASE TYPE 3	0.00190476	0.07145926231918763
MACHADO-JOSEPH DISEASE TYPE 2	0.00190476	0.07145926231918763
MACHADO-JOSEPH DISEASE TYPE 1	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.07145926231918763
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.07145926231918763
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	0.07145926231918763
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	0.07145926231918763
MEIER-GORLIN SYNDROME 6; MGORS6	0.00190476	0.07145926231918763
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00190476	0.07145926231918763
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.07145926231918763
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.07145926231918763
19Q13.11 MICRODELETION SYNDROME	0.00190476	0.07145926231918763
FRAXE INTELLECTUAL DISABILITY	0.00190476	0.07145926231918763
NAKAJO-NISHIMURA SYNDROME	0.00170358	0.06391176321516708
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00170358	0.06391176321516708
HYPERLIPOPROTEINEMIA, TYPE ID	0.00170358	0.06391176321516708
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00170358	0.06391176321516708
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00170358	0.06391176321516708
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00170358	0.06391176321516708
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00170358	0.06391176321516708
NIEMANN-PICK DISEASE, TYPE B	0.00170358	0.06391176321516708
PFAPA SYNDROME	0.00170358	0.06391176321516708
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00170358	0.06391176321516708
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00170358	0.06391176321516708
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00170358	0.06391176321516708
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00170358	0.06391176321516708
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00170358	0.06391176321516708
OPSISMODYSPLASIA	0.00170358	0.06391176321516708
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00170358	0.06391176321516708
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00170358	0.06391176321516708
SCHEIE SYNDROME	0.00170358	0.06391176321516708
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00170358	0.06391176321516708
HURLER-SCHEIE SYNDROME	0.00170358	0.06391176321516708
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00170358	0.06391176321516708
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00170358	0.06391176321516708
GLYCOGEN STORAGE DISEASE II	0.00170358	0.06391176321516708
XYLT1-CDG	0.00170358	0.06391176321516708
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00170358	0.06391176321516708
HURLER-SCHEIE SYNDROME	0.00170358	0.06391176321516708
ACROOSTEOLYSIS DOMINANT TYPE	0.00170358	0.06391176321516708
FETAL CYTOMEGALOVIRUS SYNDROME	0.00170358	0.06391176321516708
MULIBREY NANISM	0.00170358	0.06391176321516708
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00170358	0.06391176321516708
SCHNITZLER SYNDROME	0.00170358	0.06391176321516708
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00170358	0.06391176321516708
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00170358	0.06391176321516708
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00170358	0.06391176321516708
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00170358	0.06391176321516708
APOLIPOPROTEIN C-II DEFICIENCY	0.00170358	0.06391176321516708
TANGIER DISEASE; TGD	0.00170358	0.06391176321516708
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00170358	0.06391176321516708
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00170358	0.06391176321516708
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00170358	0.06391176321516708
MU-HEAVY CHAIN DISEASE	0.00170358	0.06391176321516708
CUTANEOUS MASTOCYTOSIS	0.00170358	0.06391176321516708
MAST CELL SARCOMA	0.00170358	0.06391176321516708
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00170358	0.06391176321516708
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00170358	0.06391176321516708
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00170358	0.06391176321516708
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00170358	0.06391176321516708
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00170358	0.06391176321516708
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00170358	0.06391176321516708
FAMILIAL TUMORAL CALCINOSIS	0.00170358	0.06391176321516708
PACHYONYCHIA CONGENITA	0.00170358	0.06391176321516708
ALPHA-HEAVY CHAIN DISEASE	0.00170358	0.06391176321516708
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00170358	0.06391176321516708
AREDYLD SYNDROME	0.00170358	0.06391176321516708
PYCNODYSOSTOSIS	0.00170358	0.06391176321516708
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00170358	0.06391176321516708
GAMMA-HEAVY CHAIN DISEASE	0.00170358	0.06391176321516708
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00170358	0.06391176321516708
BRONCHIAL NEUROENDOCRINE TUMOR	0.00170358	0.06391176321516708
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.00170358	0.06391176321516708
COLD AGGLUTININ DISEASE	0.00170358	0.06391176321516708
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00170358	0.06391176321516708
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00170358	0.06391176321516708
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00170358	0.06391176321516708
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00170358	0.06391176321516708
MUCKLE-WELLS SYNDROME	0.00170358	0.06391176321516708
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00170358	0.06391176321516708
MUCOLIPIDOSIS TYPE II	0.00170358	0.06391176321516708
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.00170358	0.06391176321516708
DISTAL MONOSOMY 17Q	0.00170358	0.06391176321516708
CARTILAGE-HAIR HYPOPLASIA	0.00170358	0.06391176321516708
MORQUIO SYNDROME A	0.00170358	0.06391176321516708
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00170358	0.06391176321516708
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00170358	0.06391176321516708
LCAT DEFICIENCY	0.00170358	0.06391176321516708
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00170358	0.06391176321516708
SEVERE COMBINED IMMUNODEFICIENCY	0.00170358	0.06391176321516708
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00170358	0.06391176321516708
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00170358	0.06391176321516708
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00170358	0.06391176321516708
PROLIDASE DEFICIENCY	0.00170358	0.06391176321516708
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00170358	0.06391176321516708
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00170358	0.06391176321516708
FISH-EYE DISEASE	0.00170358	0.06391176321516708
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00170358	0.06391176321516708
POLYMYOSITIS	0.00170358	0.06391176321516708
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00170358	0.06391176321516708
USHER SYNDROME	0.0014770999999999999	0.05541510551023333
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.05541510551023333
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05541510551023333
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05541510551023333
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
PENDRED SYNDROME	0.0014770999999999999	0.05541510551023333
MACHADO-JOSEPH DISEASE; MJD	0.0014770999999999999	0.05541510551023333
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05541510551023333
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05541510551023333
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05541510551023333
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05541510551023333
CHAND SYNDROME	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05541510551023333
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA, TYPE 8	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05541510551023333
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0014770999999999999	0.05541510551023333
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0014770999999999999	0.05541510551023333
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.05541510551023333
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05541510551023333
PIEBALDISM	0.0014770999999999999	0.05541510551023333
ACERULOPLASMINEMIA	0.0014770999999999999	0.05541510551023333
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.05541510551023333
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05541510551023333
GEMIGNANI SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05541510551023333
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05541510551023333
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05541510551023333
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.05541510551023333
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.0014770999999999999	0.05541510551023333
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.05541510551023333
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05541510551023333
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 31	0.0014770999999999999	0.05541510551023333
PITUITARY CARCINOMA	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.05541510551023333
GIANT CELL ARTERITIS	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05541510551023333
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.05541510551023333
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05541510551023333
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.05541510551023333
CHIARI MALFORMATION TYPE II	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05541510551023333
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05541510551023333
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.05541510551023333
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.05541510551023333
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.05541510551023333
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05541510551023333
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.05541510551023333
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05541510551023333
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05541510551023333
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05541510551023333
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05541510551023333
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05541510551023333
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0014770999999999999	0.05541510551023333
RAVINE SYNDROME	0.0014770999999999999	0.05541510551023333
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.05541510551023333
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.05541510551023333
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0014770999999999999	0.05541510551023333
STIMMLER SYNDROME	0.0014770999999999999	0.05541510551023333
NEUROFERRITINOPATHY	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 3; JBTS3	0.0014770999999999999	0.05541510551023333
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 4	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.05541510551023333
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05541510551023333
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.05541510551023333
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05541510551023333
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05541510551023333
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05541510551023333
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.05541510551023333
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.05541510551023333
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05541510551023333
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05541510551023333
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05541510551023333
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05541510551023333
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05541510551023333
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.05541510551023333
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05541510551023333
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05541510551023333
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05541510551023333
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05541510551023333
NON-DISTAL MONOSOMY 10Q	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05541510551023333
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.05541510551023333
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0014770999999999999	0.05541510551023333
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05541510551023333
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 5	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0014770999999999999	0.05541510551023333
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0014770999999999999	0.05541510551023333
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.05541510551023333
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.05541510551023333
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0014770999999999999	0.05541510551023333
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05541510551023333
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0014770999999999999	0.05541510551023333
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05541510551023333
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05541510551023333
BOUCHER-NEUHAUSER SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05541510551023333
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.05541510551023333
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
RUBINSTEIN-TAYBI SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
MONOSOMY 9Q22.3	0.001086973	0.040779042368001395
ALG3-CDG	0.001086973	0.040779042368001395
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001086973	0.040779042368001395
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040779042368001395
DISTAL TRISOMY 17Q	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040779042368001395
DISTAL MONOSOMY 1Q	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.040779042368001395
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
TETRASOMY 5P	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
STT3A-CDG	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
SCHINDLER DISEASE, TYPE I	0.001086973	0.040779042368001395
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040779042368001395
INCONTINENTIA PIGMENTI	0.001086973	0.040779042368001395
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.040779042368001395
MACDERMOT-WINTER SYNDROME	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.040779042368001395
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.040779042368001395
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001086973	0.040779042368001395
MUENKE SYNDROME	0.001086973	0.040779042368001395
VICI SYNDROME; VICIS	0.001086973	0.040779042368001395
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.040779042368001395
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.040779042368001395
BOHRING-OPITZ SYNDROME	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.040779042368001395
BAND HETEROTOPIA; BH	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
WYBURN-MASON SYNDROME	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
CODAS SYNDROME	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
MEND SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MEND SYNDROME; MEND	0.001086973	0.040779042368001395
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.040779042368001395
MAN1B1-CDG	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.040779042368001395
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.040779042368001395
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.001086973	0.040779042368001395
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040779042368001395
WALKER-WARBURG SYNDROME	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
SSR4-CDG	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.040779042368001395
PHACE SYNDROME	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.040779042368001395
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
MONOSOMY 9P	0.001086973	0.040779042368001395
DUANE RETRACTION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.040779042368001395
TARP SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040779042368001395
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.040779042368001395
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001086973	0.040779042368001395
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001086973	0.040779042368001395
15Q24 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
KABUKI SYNDROME 1	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
2Q37 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
MATERNAL PHENYLKETONURIA	0.001086973	0.040779042368001395
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.040779042368001395
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040779042368001395
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.040779042368001395
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.040779042368001395
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.040779042368001395
49,XXXXY SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
8P11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
8P23.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040779042368001395
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.040779042368001395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040779042368001395
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.040779042368001395
6Q25 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
XP21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.040779042368001395
ZTTK SYNDROME; ZTTKS	0.001086973	0.040779042368001395
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040779042368001395
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.040779042368001395
HEART AND BRAIN MALFORMATION SYNDROME	0.001086973	0.040779042368001395
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.040779042368001395
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.040779042368001395
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.040779042368001395
KOOLEN-DE VRIES SYNDROME	0.001086973	0.040779042368001395
1Q21.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MICRO SYNDROME	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.040779042368001395
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
XQ21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
RUVALCABA SYNDROME	0.001086973	0.040779042368001395
POTOCKI-SHAFFER SYNDROME	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.040779042368001395
MONOSOMY 18Q	0.001086973	0.040779042368001395
MOSAIC TRISOMY 14	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.040779042368001395
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.040779042368001395
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
FILIPPI SYNDROME	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040779042368001395
OPTIC PATHWAY GLIOMA	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.040779042368001395
DONNAI-BARROW SYNDROME	0.001086973	0.040779042368001395
COHEN SYNDROME	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.040779042368001395
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
OROTIC ACIDURIA	0.000545554	0.02046708582460892
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02046708582460892
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02046708582460892
CDAGS SYNDROME	0.000545554	0.02046708582460892
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02046708582460892
HYDROXYKYNURENINURIA	0.000545554	0.02046708582460892
TEMTAMY SYNDROME	0.000545554	0.02046708582460892
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02046708582460892
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.02046708582460892
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.02046708582460892
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME VI	0.000545554	0.02046708582460892
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.02046708582460892
MARDEN-WALKER SYNDROME	0.000545554	0.02046708582460892
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.02046708582460892
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02046708582460892
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02046708582460892
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.02046708582460892
BRESEK SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.02046708582460892
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02046708582460892
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.02046708582460892
TRISOMY 8Q	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.02046708582460892
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.02046708582460892
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02046708582460892
CURRY-JONES SYNDROME	0.000545554	0.02046708582460892
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.02046708582460892
DISTAL TRISOMY 6P	0.000545554	0.02046708582460892
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.02046708582460892
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02046708582460892
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.02046708582460892
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.02046708582460892
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.02046708582460892
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.02046708582460892
MIETENS SYNDROME	0.000545554	0.02046708582460892
3MC SYNDROME 2	0.000545554	0.02046708582460892
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.02046708582460892
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.02046708582460892
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02046708582460892
DISTAL MONOSOMY 9P	0.000545554	0.02046708582460892
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02046708582460892
SEPTOOPTIC DYSPLASIA	0.000545554	0.02046708582460892
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02046708582460892
ALG6-CDG	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.02046708582460892
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02046708582460892
N SYNDROME	0.000545554	0.02046708582460892
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.02046708582460892
CURRARINO SYNDROME	0.000545554	0.02046708582460892
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.02046708582460892
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.02046708582460892
FRONTOOCULAR SYNDROME	0.000545554	0.02046708582460892
RAINE SYNDROME	0.000545554	0.02046708582460892
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02046708582460892
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.02046708582460892
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02046708582460892
DISTAL TRISOMY 18Q	0.000545554	0.02046708582460892
CHAR SYNDROME	0.000545554	0.02046708582460892
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02046708582460892
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02046708582460892
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.02046708582460892
ROTHMUND-THOMSON SYNDROME	0.000545554	0.02046708582460892
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02046708582460892
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.02046708582460892
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.02046708582460892
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.02046708582460892
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02046708582460892
NOONAN SYNDROME 2; NS2	0.000545554	0.02046708582460892
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02046708582460892
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02046708582460892
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.02046708582460892
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02046708582460892
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02046708582460892
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
HYPERTRICHOSIS CUBITI	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.02046708582460892
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02046708582460892
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02046708582460892
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.02046708582460892
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.02046708582460892
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02046708582460892
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.02046708582460892
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02046708582460892
NOONAN SYNDROME 11; NS11	0.000545554	0.02046708582460892
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02046708582460892
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.02046708582460892
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.02046708582460892
AARSKOG-SCOTT SYNDROME	0.000545554	0.02046708582460892
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.02046708582460892
ICF SYNDROME	0.000545554	0.02046708582460892
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02046708582460892
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.02046708582460892
COLE-CARPENTER SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02046708582460892
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.02046708582460892
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02046708582460892
OGDEN SYNDROME; OGDNS	0.000545554	0.02046708582460892
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.02046708582460892
3C SYNDROME	0.000545554	0.02046708582460892
ZECHI-CEIDE SYNDROME	0.000545554	0.02046708582460892
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02046708582460892
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02046708582460892
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.02046708582460892
JOUBERT SYNDROME 10	0.000545554	0.02046708582460892
JAWAD SYNDROME	0.000545554	0.02046708582460892
PETERS PLUS SYNDROME	0.000545554	0.02046708582460892
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02046708582460892
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02046708582460892
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.02046708582460892
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02046708582460892
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02046708582460892
TURNPENNY-FRY SYNDROME; TPFS	0.000545554	0.02046708582460892
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
TRISOMY 9P	0.000545554	0.02046708582460892
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02046708582460892
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.02046708582460892
ATELOSTEOGENESIS TYPE III	0.000545554	0.02046708582460892
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02046708582460892
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.02046708582460892
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.02046708582460892
RING CHROMOSOME 12 SYNDROME	0.000545554	0.02046708582460892
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02046708582460892
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
LOWRY-MACLEAN SYNDROME	0.000545554	0.02046708582460892
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.02046708582460892
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02046708582460892
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.02046708582460892
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02046708582460892
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02046708582460892
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02046708582460892
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02046708582460892
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02046708582460892
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02046708582460892
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02046708582460892
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02046708582460892
ZEBRA BODY MYOPATHY	0.000545554	0.02046708582460892
AURICULOCONDYLAR SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02046708582460892
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02046708582460892
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02046708582460892
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02046708582460892
RABSON-MENDENHALL SYNDROME	0.000545554	0.02046708582460892
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.02046708582460892
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02046708582460892
TOLUENE EMBRYOPATHY	0.000545554	0.02046708582460892
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02046708582460892
TARP SYNDROME; TARPS	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02046708582460892
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.02046708582460892
RIGID SPINE SYNDROME	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02046708582460892
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.02046708582460892
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.02046708582460892
AU-KLINE SYNDROME; AUKS	0.000545554	0.02046708582460892
NOONAN SYNDROME 9; NS9	0.000545554	0.02046708582460892
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.02046708582460892
CONGENITAL VARICELLA SYNDROME	0.000545554	0.02046708582460892
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.02046708582460892
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02046708582460892
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.02046708582460892
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02046708582460892
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02046708582460892
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02046708582460892
CHOPS SYNDROME; CHOPS	0.000545554	0.02046708582460892
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.02046708582460892
TRISOMY 18	0.000545554	0.02046708582460892
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.02046708582460892
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02046708582460892
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.02046708582460892
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.02046708582460892
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.02046708582460892
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.02046708582460892
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.02046708582460892
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.02046708582460892
SECKEL SYNDROME 9; SCKL9	0.000545554	0.02046708582460892
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02046708582460892
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02046708582460892
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02046708582460892
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.02046708582460892
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.02046708582460892
STEEL SYNDROME; STLS	0.000545554	0.02046708582460892
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.02046708582460892
TYSHCHENKO SYNDROME	0.000545554	0.02046708582460892
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.02046708582460892
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02046708582460892
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.02046708582460892
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02046708582460892
ALAZAMI SYNDROME; ALAZS	0.000545554	0.02046708582460892
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.02046708582460892
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.02046708582460892
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02046708582460892
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02046708582460892
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 11	0.000545554	0.02046708582460892
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02046708582460892
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.02046708582460892
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02046708582460892
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02046708582460892
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02046708582460892
XIA-GIBBS SYNDROME	0.000545554	0.02046708582460892
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.02046708582460892
ISOLATED PLAGIOCEPHALY	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 2	0.000545554	0.02046708582460892
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02046708582460892
CULLER-JONES SYNDROME; CJS	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02046708582460892
COSTELLO SYNDROME; CSTLO	0.000545554	0.02046708582460892
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.02046708582460892
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02046708582460892
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02046708582460892
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02046708582460892
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02046708582460892
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02046708582460892
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02046708582460892
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02046708582460892
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.02046708582460892
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.02046708582460892
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.02046708582460892
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02046708582460892
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.02046708582460892
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02046708582460892
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.02046708582460892
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.02046708582460892
AUSTRALIA ANTIGEN	0.000545554	0.02046708582460892
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02046708582460892
WEAVER SYNDROME	0.000545554	0.02046708582460892
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02046708582460892
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 26	0.000545554	0.02046708582460892
ALAZAMI-YUAN SYNDROME	0.000545554	0.02046708582460892
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.02046708582460892
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.02046708582460892
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.02046708582460892
ABETAL34V AMYLOIDOSIS	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02046708582460892
FRIAS SYNDROME	0.000545554	0.02046708582460892
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.02046708582460892
NOONAN SYNDROME 3; NS3	0.000545554	0.02046708582460892
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.02046708582460892
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02046708582460892
MEIER-GORLIN SYNDROME 7	0.000545554	0.02046708582460892
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02046708582460892
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02046708582460892
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.02046708582460892
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.02046708582460892
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02046708582460892
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.02046708582460892
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.02046708582460892
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.02046708582460892
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02046708582460892
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02046708582460892
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.02046708582460892
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.02046708582460892
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.02046708582460892
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02046708582460892
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02046708582460892
FRIED SYNDROME	0.000545554	0.02046708582460892
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02046708582460892
TRISOMY 17P	0.000545554	0.02046708582460892
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.02046708582460892
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.02046708582460892
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.02046708582460892
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02046708582460892
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.02046708582460892
RAHMAN SYNDROME	0.000545554	0.02046708582460892
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.02046708582460892
ATHYREOSIS	0.000545554	0.02046708582460892
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02046708582460892
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.02046708582460892
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.02046708582460892
CHAR SYNDROME	0.000545554	0.02046708582460892
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.02046708582460892
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02046708582460892
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.02046708582460892
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02046708582460892
HYDROXYKYNURENINURIA	0.000545554	0.02046708582460892
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02046708582460892
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02046708582460892
NOONAN SYNDROME 5; NS5	0.000545554	0.02046708582460892
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
OGDEN SYNDROME	0.000545554	0.02046708582460892
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02046708582460892
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02046708582460892
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02046708582460892
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.02046708582460892
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.02046708582460892
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02046708582460892
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.02046708582460892
LATERAL MENINGOCELE SYNDROME	0.000545554	0.02046708582460892
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.02046708582460892
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.02046708582460892
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.02046708582460892
EVEN-PLUS SYNDROME	0.000545554	0.02046708582460892
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02046708582460892
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02046708582460892
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02046708582460892
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.02046708582460892
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.02046708582460892
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.02046708582460892
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.02046708582460892
OPITZ G/BBB SYNDROME	0.000545554	0.02046708582460892
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.02046708582460892
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.02046708582460892
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.02046708582460892
TREACHER-COLLINS SYNDROME	0.000545554	0.02046708582460892
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.02046708582460892
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02046708582460892
PHENYLKETONURIA	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392472
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392472
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392472
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
COHEN SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392472
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392472
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392472
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020311956543392472
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392472
MOGS-CDG	0.000541419	0.020311956543392472
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
FRAGILE X SYNDROME	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392472
ALG2-CDG	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392472
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020311956543392472
HADDAD SYNDROME	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392472
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392472
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020311956543392472
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000541419	0.020311956543392472
MARDEN-WALKER SYNDROME	0.000541419	0.020311956543392472
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
MEHMO SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
KRABBE DISEASE	0.000541419	0.020311956543392472
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392472
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392472
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392472
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392472
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
ADDISON DISEASE	0.000541419	0.020311956543392472
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392472
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392472
CROME SYNDROME	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392472
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392472
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
CROUZON SYNDROME	0.000541419	0.020311956543392472
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392472
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392472
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020311956543392472
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392472
OHDO SYNDROME	0.000541419	0.020311956543392472
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392472
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
INSULINOMA	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392472
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392472
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392472
MPDU1-CDG	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
MOYNAHAN SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.020311956543392472
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392472
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020311956543392472
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392472
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392472
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392472
MOMO SYNDROME	0.000541419	0.020311956543392472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392472
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392472
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392472
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392472
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392472
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
AICA-RIBOSIDURIA	0.000541419	0.020311956543392472
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392472
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
PINEOBLASTOMA	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392472
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392472
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392472
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392472
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392472
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392472
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392472
15Q OVERGROWTH SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020311956543392472
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392472
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392472
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392472
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392472
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
PROLACTINOMA	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392472
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392472
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392472
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392472
COFFIN-LOWRY SYNDROME	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
CADASIL	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392472
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392472
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392472
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392472
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392472
DISTAL MONOSOMY 3P	0.000541419	0.020311956543392472
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392472
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392472
KNOBLOCH SYNDROME	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392472
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
CRISPONI SYNDROME	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392472
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392472
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392472
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020311956543392472
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392472
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392472
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392472
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392472
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392472
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392472
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
KABUKI SYNDROME	0.000541419	0.020311956543392472
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392472
MOWAT-WILSON SYNDROME	0.000541419	0.020311956543392472
FRYNS SYNDROME	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392472
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392472
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
HARROD SYNDROME	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392472
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392472
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
DPM1-CDG	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392472
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392472
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
MENKES DISEASE	0.000541419	0.020311956543392472
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
HHHH SYNDROME	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392472
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392472
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392472
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392472
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
WHIM SYNDROME	0.000541419	0.020311956543392472
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392472
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392472
RETT SYNDROME; RTT	0.000541419	0.020311956543392472
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
DEND SYNDROME	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392472
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392472
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392472
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392472
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
PORPHYRIA	0.000541419	0.020311956543392472
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392472
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392472
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392472
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392472
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
PERRAULT SYNDROME 3	0.000541419	0.020311956543392472
ADIPOSIS DOLOROSA	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392472
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.020311956543392472
GALACTOSIALIDOSIS	0.000541419	0.020311956543392472
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392472
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
RENPENNING SYNDROME	0.000541419	0.020311956543392472
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392472
TAKAYASU ARTERITIS	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020311956543392472
CHIME SYNDROME	0.000541419	0.020311956543392472
TETRASOMY 18P	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392472
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392472
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392472
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392472
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392472
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392472
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392472
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392472
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392472
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.020311956543392472
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392472
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392472
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020311956543392472
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
MALAN OVERGROWTH SYNDROME	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392472
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392472
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392472
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020311956543392472
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA	0.000541419	0.020311956543392472
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392472
